Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
AIDS
    October 2021
  1. BOZZI G, Meneri M, Peri AM, Taramasso L, et al
    Starting HIV therapy in patients with mitochondrial disease.
    AIDS. 2021;35:2063-2065.
    >> Share

  2. SARKAR S, Haberlen S, Metkus TS, Kingsley L, et al
    HIV serostatus and incident coronary artery stenosis in men with a baseline zero coronary artery calcium.
    AIDS. 2021;35:2061-2063.
    >> Share

  3. TOMIO A, Lupo J, Blanc M, Epaulard O, et al
    Dynamics of anti-HBs antibody decay in vaccinated people with HIV/AIDS.
    AIDS. 2021;35:2059-2061.
    >> Share

  4. HOOVER JR, Frymus DE, Ifafore-Calfee TA
    Recognizing and supporting health workers to advance and sustain HIV gains: lessons from PEPFAR programmes during the COVID-19 response.
    AIDS. 2021;35:2047-2050.
    >> Share

  5. WEINSTEIN ER, Lee JS, Mendez NA, Harkness A, et al
    HIV/AIDS and aging: the new frontier for HIV/AIDS research and care.
    AIDS. 2021;35:2043-2045.
    >> Share

  6. SANDERS EJ, Agutu CA, Graham SM
    Multiple HIV testing strategies are necessary to end AIDS.
    AIDS. 2021;35:2039-2041.
    >> Share

  7. KOENIG LJ, McKnight-Eily LR
    Achieving national HIV prevention goals: the case for addressing depression and other mental health comorbidities.
    AIDS. 2021;35:2035-2037.
    >> Share

  8. NACCARATO M, Kwee F, Zaltzman J, Fong IW, et al
    Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?
    AIDS. 2021;35:2065-2068.
    >> Share

    September 2021
  9. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy-naive adults with HIV-1 infection.
    AIDS. 2021 Sep 15. pii: 00002030-900000000-96314.
    >> Share

  10. N'TAKPE JB, Gabillard D, Moh R, Gardiennet E, et al
    Elite and viremic HIV-1 controllers in West Africa.
    AIDS. 2021 Sep 14. pii: 00002030-900000000-96315.
    >> Share

  11. QU Y, Weinstein A, Wang Z, Cheng Y, et al
    Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy.
    AIDS. 2021 Sep 13. pii: 00002030-900000000-96316.
    >> Share

  12. STENGER MR, Pathela P, Schumacher C, Burghardt N, et al
    Trends in HIV prevalence by self-report among MSM diagnosed and 1 reported with gonorrhea in six U.S. jurisdictions, 2010-2019.
    AIDS. 2021 Sep 10. pii: 00002030-900000000-96317.
    >> Share

  13. CORLEY MJ, Pang APS, Rasmussen TA, Tolstrup M, et al
    Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96322.
    >> Share

  14. FRANCO S, Horneros J, Soldevila L, Ouchi D, et al
    Single nucleotide polymorphisms in PNPLA3, ADAR-1, and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1/HCV.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96321.
    >> Share

  15. CHOW FC, Callen A, Arechiga V, Saloner D, et al
    Intracranial vascular imaging detects arterial wall abnormalities in persons with treated HIV infection.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96320.
    >> Share

  16. YAGER JL, Brooks KM, Castillo-Mancilla JR, Nemkov C, et al
    Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium, and high adherence to F/TAF vs. F/TDF.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96319.
    >> Share

  17. ABRAHAM AG, Sun J, Sharma A, Yin MT, et al
    The combined effects of age and HIV on the anatomic distribution of cortical and cancellous bone in the femoral neck among men and women.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96318.
    >> Share

  18. CHAN C, Patel P, Johnson K, Vaughan M, et al
    Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia.
    AIDS. 2021;35:1878-1880.
    >> Share

  19. WANG Y, Feng R, Xu J, Shi L, et al
    An updated meta-analysis on the association between HIV infection and COVID-19 mortality.
    AIDS. 2021;35:1875-1878.
    >> Share

  20. VANCE DE, Becker JT
    Using HIV neuropsychological classification methods to predict employment status.
    AIDS. 2021;35:1859-1861.
    >> Share

  21. DOSHI RK, Greenberg AE
    Test, treat, and maintain: rapid initiation of antiretroviral therapy.
    AIDS. 2021;35:1867-1869.
    >> Share

  22. CRAWFORD KW, Nathan M
    Anal neoplasia: prevention or treatment?
    AIDS. 2021;35:1863-1865.
    >> Share

  23. SEELEY J
    Social context and tracing household wealth over time in rural Uganda 1994-2018.
    AIDS. 2021;35:1857-1858.
    >> Share

  24. SANTELLI JS, Chen I, Makumbi F, Wei Y, et al
    Household wealth and HIV incidence over time, rural Uganda, 1994-2018.
    AIDS. 2021;35:1835-1843.
    >> Share

  25. CROWELL TA, Daud II, Maswai J, Owuoth J, et al
    SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020.
    AIDS. 2021 Sep 1. pii: 00002030-900000000-96325.
    >> Share

    August 2021
  26. VISHWANATHAN SA, Zhao C, Luthra R, Khalil GK, et al
    Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from SHIV acquisition by long-acting cabotegravir in macaques.
    AIDS. 2021 Aug 20. pii: 00002030-900000000-96329.
    >> Share

  27. DAMAS J, Ledergerber B, Nadin I, Tarr PE, et al
    Neurocognitive course at two-year follow-up in the neurocognitive assessment in the metabolic and aging cohort (NAMACO) study.
    AIDS. 2021 Aug 19. pii: 00002030-900000000-96330.
    >> Share

  28. MARASINI B, Vyas HK, Lakhashe SK, Hariraju D, et al
    Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
    AIDS. 2021 Aug 16. pii: 00002030-900000000-96332.
    >> Share

  29. LLOYD AR, Savage R, Eaton E
    Opioid use disorder: a neglected human immunodeficiency virus risk in American adolescents.
    AIDS. 2021 Aug 13. pii: 00002030-900000000-96331.
    >> Share

  30. PREMEAUX TA, Moser CB, McKhann A, Hoenigl M, et al
    Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
    AIDS. 2021 Aug 6. pii: 00002030-900000000-96334.
    >> Share

  31. DAH TTE, Yaya I, Mensah E, Coulibaly A, et al
    Rapid antiretroviral therapy initiation and its effect on treatment response in men who have sex with men in West Africa.
    AIDS. 2021 Aug 4. pii: 00002030-900000000-96335.
    >> Share

  32. PASTICCI MB, De Socio GV, Gagliardini R, Merlini E, et al
    Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse.
    AIDS. 2021;35:1708-1710.
    >> Share

  33. MICAN R, Busca Arenzana C, Vasquez J, Daroca G, et al
    Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.
    AIDS. 2021;35:1707-1708.
    >> Share

  34. VAN HOEK AJ, Reitsema M, Xiridou M, van Sighem A, et al
    Offering a choice of daily and event-driven preexposure prophylaxis for men who have sex with men in the Netherlands: a cost-effectiveness analysis.
    AIDS. 2021;35:1677-1682.
    >> Share

  35. BAUGHER AR, Whiteman A, Jeffries WL 4th, Finlayson T, et al
    Black men who have sex with men living in states with HIV criminalization laws report high stigma, 23 U.S. cities, 2017.
    AIDS. 2021;35:1637-1645.
    >> Share

  36. MILLAR JR, Fatti I, Mchunu N, Bengu N, et al
    Second-generation mother-to-child HIV transmission in South Africa is characterized by poor outcomes.
    AIDS. 2021;35:1597-1604.
    >> Share

  37. PRENDERGAST AJ, Szubert AJ, Pimundu G, Berejena C, et al
    The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
    AIDS. 2021;35:1537-1548.
    >> Share

  38. MARCHETTI G, Asmuth D
    Women are from venus: implications for diversified sex-based preexposure prophylaxis approaches.
    AIDS. 2021;35:1691-1693.
    >> Share

  39. WINSLOW DL
    Hepatitis C virus infection and cardiac dysfunction in women.
    AIDS. 2021;35:1689-1690.
    >> Share

    July 2021
  40. MORAKA NO, Garcia-Broncano P, Hu Z, Ajibola G, et al
    Patterns of pre-treatment drug resistance mutations of very early diagnosed and treated infants in botswana.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96339.
    >> Share

  41. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared to HIV-unexposed.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96338.
    >> Share

  42. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Multimorbidity networks associated with frailty among middle aged and older people with HIV.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96337.
    >> Share

  43. TOSKA E, Zhou S, Laurenzi CA, Haghighat R, et al
    Predictors of secondary HIV transmission risk in a cohort of adolescents living with HIV in South Africa.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96336.
    >> Share

  44. WANG M, Boeke CE, Rioja MR, Maparo T, et al
    Feasibility and impact of near-point-of-care integrated TB/HIV testing in Malawi and Zimbabwe.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96342.
    >> Share

  45. DRAK D, Mcmanus H, Vickers T, Heron JE, et al
    Renal impairment in a large-scale HIV pre-exposure prophylaxis implementation cohort.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96341.
    >> Share

  46. SEKHAR RV
    Supplementing glycine and N-acetylcysteine (GlyNAC) rapidly improves health-related quality of life and lowers perception of fatigue in patients with HIV.
    AIDS. 2021;35:1522-1524.
    >> Share

  47. PAPAMANOLI A, Psevdos G
    False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection.
    AIDS. 2021;35:1521-1522.
    >> Share

  48. DOWNING JM, Prince DJ, Sun CJ
    Prevalence of HIV testing among black and white transgender adults, 2016-2019.
    AIDS. 2021;35:1519-1520.
    >> Share

  49. TAN CS, Reeves RK
    HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?
    AIDS. 2021;35:1503-1504.
    >> Share

  50. IPSER JC, Vera JH
    Does duration of HIV infection substitute for age as a risk factor for amyloid deposition?
    AIDS. 2021;35:1501-1502.
    >> Share

  51. PECHEUR EI
    Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis?
    AIDS. 2021;35:1499-1500.
    >> Share

  52. WINSLOW DL
    Pediatric liquid 'single tablet regimens' for HIV-a call to action.
    AIDS. 2021;35:1497-1498.
    >> Share

  53. MCBRIDE B, Shannon K, Strathdee SA, Goldenberg SM, et al
    Structural determinants of HIV/STI prevalence, HIV/STI/sexual and reproductive health access, and condom use among immigrant sex workers globally.
    AIDS. 2021;35:1461-1477.
    >> Share

  54. MARUKUTIRA T, Wood BR
    Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings.
    AIDS. 2021;35:1505-1507.
    >> Share

  55. RAMOS-RINCON JM, Pinargote H, Ramos-Belinchon C, de Mendoza C, et al
    Hepatitis delta in patients hospitalized in Spain (1997-2018).
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96346.
    >> Share

  56. SWINDELLS S, Lutz T, van Zyl L, Porteiro N, et al
    Long-acting cabotegravir + rilpivirine for HIV-1 treatment: ATLAS week 96 results.
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96345.
    >> Share

  57. GODIN A, Eaton JW, Giguere K, Marsh K, et al
    Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96350.
    >> Share

  58. ASIF S, Baxevanidi E, Hill A, Venter F, et al
    The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96351.
    >> Share

  59. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    >> Share

  60. VYAS P, Mathad JS, Leu CS, Naik S, et al
    Impact of HIV status on systemic inflammation during pregnancy.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96348.
    >> Share

  61. AKGUN KM, Krishnan S, Butt AA, Gibert CL, et al
    HIV-infected medical ICU (MICU) survivors without CD4 cell recovery are at increased risk for poor outcomes regardless of viral suppression in a national cohort.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96347.
    >> Share

  62. RONCHETTI AM, Matheron S, Galicier L, Damond F, et al
    Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era.
    AIDS. 2021 Jul 6. pii: 00002030-900000000-96352.
    >> Share

  63. MACPHAIL AI, McLean C, Vujovic O, Hoy JF, et al
    A 44-year-old man with an ulcerating skin rash in the setting of advanced human immunodeficiency virus infection.
    AIDS. 2021;35:1325-1326.
    >> Share

  64. LASRY A, Baker-Goering M
    Cost analyses of HIV treatment should be standardized and report cost drivers.
    AIDS. 2021;35:1311-1312.
    >> Share

  65. DASH PK, Akay-Espinoza C
    FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients.
    AIDS. 2021;35:1309-1310.
    >> Share

  66. DASH PK, Boix V
    Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
    AIDS. 2021;35:1301-1303.
    >> Share

  67. VELDSMAN KA, Laughton B, Janse van Rensburg A, Zuidewind P, et al
    Viral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of age.
    AIDS. 2021;35:1247-1252.
    >> Share

  68. IMBERT E, Hickey MD, Clemenzi-Allen A, Lynch E, et al
    Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
    AIDS. 2021;35:1241-1246.
    >> Share

  69. MOMPER JD, Wang J, Stek A, Shapiro DE, et al
    Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.
    AIDS. 2021;35:1191-1199.
    >> Share

  70. CATTANEO D, Bernacchia D, Beltrami M, Resnati C, et al
    When the absence of an interaction can become clinically relevant.
    AIDS. 2021;35:1327-1328.
    >> Share

  71. WOOD BR, Pozniak AL
    Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!
    AIDS. 2021;35:1305-1307.
    >> Share

  72. KANNO Y, Hau TTT, Kurokawa R, Nomura T, et al
    Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused SIV controllers.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96355.
    >> Share

  73. JIJ OACUTE N SIA, Molina JM, Costagliola D, Supervie V, et al
    Can HIV epidemics among men who have sex with men be eliminated through participation in PrEP rollouts?
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96354.
    >> Share

  74. MWASAKIFWA GE, Amin J, Kelleher A, Boyd MA, et al
    Inflammatory biomarker and soft tissue changes among patients commencing second-line ART after first-line virological failure.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96353.
    >> Share

    June 2021
  75. SANTOS JCV, Orsi JSR, Ribeiro VS, Tuon FF, et al
    The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96357.
    >> Share

  76. GILMORE JC, Zhang G, Cameron DW, Serghides L, et al
    Impact of in utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96356.
    >> Share

  77. LESKO CR, Hutton HE, Fojo AT, Shen NM, et al
    Depression and HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96361.
    >> Share

  78. LIU G, Mugo NR, Brown ER, Mgodi NM, et al
    Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96360.
    >> Share

  79. BURKE RM, Henrion MYR, Mallewa J, Masamba L, et al
    Incidence of HIV-positive admission and inpatient mortality in Malawi [2012-2019]: a population cohort study.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96359.
    >> Share

  80. CREPAZ N, Song R, Lyss S, Hall HI, et al
    Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014-2018.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96358.
    >> Share

  81. MHLEKUDE B, Lenman A, Sidoyi P, Joseph J, et al
    The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission.
    AIDS. 2021 Jun 21. pii: 00002030-900000000-96362.
    >> Share

  82. KREBS E, Enns E, Zang X, Mah CS, et al
    Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US cities.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96365.
    >> Share

  83. SUZUKI K, Levert A, Yeung J, Starr M, et al
    HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96364.
    >> Share

  84. ROWLINSON E, Mawandia S, Ledikwe J, Bakae O, et al
    HIV testing criteria to reduce testing volume and increase positivity in Botswana.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96367.
    >> Share

  85. ZIMBA S, Nutakki A, Chishimba L, Chomba M, et al
    Risk factors and outcomes of HIV-associated stroke in Zambia.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96366.
    >> Share

  86. CHAN TY, De Zan V, Gregg A, Alagaratnam J, et al
    Cerebrospinal fluid HIV RNA escape symptomatology.
    AIDS. 2021 Jun 15. pii: 00002030-900000000-96370.
    >> Share

  87. GRANGER LA, Huettner I, Debeljak F, Kaleebu P, et al
    Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection SPARTAC cohort.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96373.
    >> Share

  88. MORROW M, Mawhinney S, Coyle RP, Coleman SS, et al
    Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96372.
    >> Share

  89. FAJNZYLBER J, Sharaf R, Hutchinson JN, Aga E, et al
    Frequency of Post Treatment Control Varies by ART Restart and Viral Load Criteria.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96371.
    >> Share

  90. SHEN Y, Shiau S, Strehlau R, Burke M, et al
    Persistently lower bone mass and bone turnover among south african children living with well-controlled HIV.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96369.
    >> Share

  91. GENBERG BL, Wilson-Barthes MG, Omodi V, Hogan JW, et al
    Microfinance, retention in care, and mortality among patients enrolled in HIV 2 Care in East Africa.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96376.
    >> Share

  92. CLAYTOR JD, Viramontes O, Conner S, Wen KW, et al
    TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96375.
    >> Share

  93. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    >> Share

  94. NWOGU JN, Gandhi M, Owen A, Khoo S, et al
    Associations between efavirenz concentrations, pharmacogenetics, and neurocognitive performance in people living with HIV in Nigeria.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96381.
    >> Share

  95. ROLLE CP, Berhe M, Singh T, Ortiz R, et al
    Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96380.
    >> Share

  96. HEATH K, Levi J, Hill A
    Reaching UNAIDS 95-95-95 targets worldwide: predicted benefits and treatment costs with generic manufacture.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96379.
    >> Share

  97. ROBERTSON J, Eden A, Nystrom K, Hagberg L, et al
    Increased immune activation and signs of neuronal injury in HIV-negative people on pre-exposure prophylaxis (PrEP).
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96378.
    >> Share

  98. KOEHN K, Cassidy-Matthews C, Pearce M, Aspin C, et al
    Rates of new HIV diagnoses among Indigenous peoples in Canada, Australia, New Zealand, and the United States: 2009-2017.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96377.
    >> Share

  99. GABRIEL EM, Salinas TRW, Gosselin A, Larouche-Anctil E, et al
    Overt IL-32 Isoform Expression at Intestinal Level during HIV-1 Infection is Negatively Regulated by IL-17A.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96384.
    >> Share

  100. HERRERA C, Harman S, Aldon Y, Rogers P, et al
    The entry inhibitor DS003 (BMS-599793), a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96382.
    >> Share

  101. ANDREIA A, Cappello C, Stirrup O
    High-risk hpv, precancerous lesions and cancer in anal condylomas: systematic review and meta-analysis.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96383.
    >> Share

  102. GUARDIGNI V, Toschi A, Badia L, Del Turco ER, et al
    Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96387.
    >> Share

  103. JIN F, Amin J, Guy R, Vaccher S, et al
    Adherence to daily HIV Pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96386.
    >> Share

  104. MAKADZANGE TA, Hlupeni A, Machekano R, Boyd K, et al
    Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96385.
    >> Share

  105. PETERSON M, Sarita Shah N, Smith-Jeffcoat SE, Nichols C, et al
    Global progress and gaps in tuberculosis screening and treatment among people with HIV: experience from 32 countries.
    AIDS. 2021;35:1154-1156.
    >> Share

  106. NIGHTINGALE S, Dreyer AJ, Gisslen M, Winston A, et al
    Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
    AIDS. 2021;35:1152-1153.
    >> Share

  107. WIERSINGA WJ, van der Valk M
    Severe coronavirus disease 2019 in a patient with HIV-2 infection.
    AIDS. 2021;35:1151-1152.
    >> Share

  108. VIEIRA VA, Fairlie L
    Effects of preconception antiretroviral therapy in placenta development and pregnancy outcomes.
    AIDS. 2021;35:1139-1141.
    >> Share

  109. ROMANELLI A, Moore D
    The importance of wearables: sleep assessment devices for people with HIV.
    AIDS. 2021;35:1137-1138.
    >> Share

  110. RICHMAN DD
    Disregarding drug resistance mutations without peril.
    AIDS. 2021;35:1135-1136.
    >> Share

  111. BOYD AT, Ogbanufe O, Onyenuobi C, Mgbakor I, et al
    Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020.
    AIDS. 2021;35:1127-1134.
    >> Share

  112. BOURDON M, Garnier A, Maignien C, Marcellin L, et al
    Assisted reproductive technology outcomes in women with a chronic viral disease.
    AIDS. 2021;35:1073-1081.
    >> Share

  113. ACKERMAN P, Thompson M, Molina JM, Aberg J, et al
    Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1.
    AIDS. 2021;35:1061-1072.
    >> Share

  114. PENG AT, Huang SH, Sun HY, Huang YC, et al
    Use of dietary supplements containing polyvalent cations and antacids among people living with HIV and its impact on viral suppression.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96390.
    >> Share

  115. HAMEIRI-BOWEN D, Sovershaeva E, Flaegstad T, Gutteberg TJ, et al
    Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96389.
    >> Share

  116. APARICIO JM, Xu Y, Li Y, Colantuoni C, et al
    Plasma microRNAs are associated with domain-specific cognitive function in people with HIV.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96388.
    >> Share

    May 2021
  117. BADE AN, Gendelman HE, McMillan J, Liu Y, et al
    Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue.
    AIDS. 2021 May 27. pii: 00002030-900000000-96396.
    >> Share

  118. STIER EA, Engels E, Horner MJ, Robinson B, et al
    Cervical cancer incidence stratified by age in women living with HIV compared with the general population in the United States, 2002-2016.
    AIDS. 2021 May 27. pii: 00002030-900000000-96395.
    >> Share

  119. PAPASAVVAS E, Azzoni L, Ross BN, Fair M, et al
    Comparable HIV suppression by pegylated-IFN-alpha2a or pegylated-IFN-alpha2b during a 4-week analytical treatment interruption.
    AIDS. 2021 May 27. pii: 00002030-900000000-96394.
    >> Share

  120. CHAPPELL E
    Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand.
    AIDS. 2021 May 27. pii: 00002030-900000000-96393.
    >> Share

  121. CORMA-GOMEZ A, Macias J, Tellez F, Morano L, et al
    Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
    AIDS. 2021 May 27. pii: 00002030-900000000-96392.
    >> Share

  122. YU X, Westra JR, Giordano TP, Berenson AB, et al
    Assessing comorbidities and survival in HIV-infected and uninfected matched Medicare enrollees.
    AIDS. 2021 May 27. pii: 00002030-900000000-96391.
    >> Share

  123. TEMU TM, Wagoner J, Masyuko S, O'Connor A, et al
    Central obesity is a contributor to systemic inflammation and monocyte activation in virally suppressed adults with chronic HIV in Kenya.
    AIDS. 2021 May 24. pii: 00002030-900000000-96400.
    >> Share

  124. KOWALSKA JD, Pelchen-Matthews A, Ryom L, Losso MH, et al
    Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015.
    AIDS. 2021 May 24. pii: 00002030-900000000-96399.
    >> Share

  125. NOVITSKY V, Steingrimsson J, Howison M, Dunn C, et al
    Longitudinal typing of molecular HIV clusters in a statewide epidemic.
    AIDS. 2021 May 24. pii: 00002030-900000000-96398.
    >> Share

  126. TU W, Johnson E, Fujiwara E, Gill MJ, et al
    Predictive variables for peripheral neuropathy in treated HIV-1 infection revealed by machine learning.
    AIDS. 2021 May 24. pii: 00002030-900000000-96397.
    >> Share

  127. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Mutunga L, et al
    High conversion of tuberculin skin tests during the first year of ART among South African adults in primary care.
    AIDS. 2021 May 19. pii: 00002030-900000000-96402.
    >> Share

  128. SILVERA R, Martinson T, Gaisa MM, Liu Y, et al
    The other side of screening: predictors of treatment and follow-up for anal precancers in a large health system.
    AIDS. 2021 May 19. pii: 00002030-900000000-96401.
    >> Share

  129. VAN DEN ELSHOUT MAM, Hoornenborg E, Achterbergh RCA, Coyer L, et al
    Improving adherence to daily PrEP among MSM in Amsterdam by providing feedback via a mobile application.
    AIDS. 2021 May 17. pii: 00002030-900000000-96403.
    >> Share

  130. PASTORI C, Galli L, Siracusano G, Spagnuolo V, et al
    Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1 infected subjects.
    AIDS. 2021 May 14. pii: 00002030-900000000-96404.
    >> Share

  131. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    >> Share

  132. DHAIRYAWAN R, Okhai H, Hill T, Sabin CA, et al
    Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity.
    AIDS. 2021 May 10. pii: 00002030-900000000-96411.
    >> Share

  133. HAMADY A, Cooke GS, Garvey LJ
    Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.
    AIDS. 2021 May 10. pii: 00002030-900000000-96410.
    >> Share

  134. CHADWICK D, Forbes G, Lawrence C, Lorrimer S, et al
    Using an electronic health record alert to prompt blood-borne virus testing in primary care.
    AIDS. 2021 May 10. pii: 00002030-900000000-96408.
    >> Share

  135. PATHELA P, Jamison K, Braunstein SL, Borges CM, et al
    Initiating antiretroviral treatment for newly diagnosed HIV patients in sexual health clinics greatly improves timeliness of viral suppression.
    AIDS. 2021 May 10. pii: 00002030-900000000-96407.
    >> Share

  136. KEENE CM, Griesel R, Zhao Y, Gcwabe Z, et al
    Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line in adults failing a tenofovir-based first-line regimen: a prospective cohort study.
    AIDS. 2021 May 10. pii: 00002030-900000000-96409.
    >> Share

  137. MACHINGURA F, Chabata S, Busza J, Jamali G, et al
    Potential reduction in female sex workers' risk of contracting HIV during Covid-19.
    AIDS. 2021 May 7. pii: 00002030-900000000-96406.
    >> Share

  138. ROYSTON L, Isnard S, Calmy A, Routy JP, et al
    Kaposi sarcoma in ART-treated people living with HIV: A wake-up call for research on HHV-8.
    AIDS. 2021 May 5. pii: 00002030-900000000-96414.
    >> Share

  139. GARBER DA, Guenthner P, Mitchell J, Ellis S, et al
    Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.
    AIDS. 2021 May 5. pii: 00002030-900000000-96412.
    >> Share

  140. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    >> Share

  141. KUMWENDA T, Buleya S, Matanje B, Heller T, et al
    Cardiovascular risk assessment for primary prevention in Malawian HIV patients on ART: are measurements of glycated hemoglobin and lipids worth the effort?
    AIDS. 2021;35:997-999.
    >> Share

  142. LAPARRA A, Lerolle N, Gerin M, Cheret A, et al
    Tumor necrosis factor-alpha inhibitors for extended or severe neurological immune reconstitution inflammatory syndrome in HIV-infected patients.
    AIDS. 2021;35:995-997.
    >> Share

  143. TARAMASSO L, Stapleton JT, Siedner MJ
    Weight gain and aging in people with HIV.
    AIDS. 2021;35:987-989.
    >> Share

  144. CHAKRABORTY R
    Maternal HIV infection and antiretroviral exposure during pregnancy in fetuses and newborns: when solving one problem opens up a Pandora's box of new conundrums.
    AIDS. 2021;35:985-986.
    >> Share

  145. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed.
    AIDS. 2021;35:921-931.
    >> Share

  146. SHADE SB, Osmand T, Kwarisiima D, Brown LB, et al
    Costs of integrating hypertension care into HIV care in rural East African clinics.
    AIDS. 2021;35:911-919.
    >> Share

  147. LEAL VNC, Reis EC, Fernandes FP, Soares JLDS, et al
    Common pathogen-associated molecular patterns induce the hyper-activation of NLRP3 inflammasome in circulating B lymphocytes of HIV-infected individuals.
    AIDS. 2021;35:899-910.
    >> Share

  148. CHAN MS, Morales A, Zlotorzynska M, Sullivan P, et al
    Estimating the influence of Twitter on pre-exposure prophylaxis use and HIV testing as a function of rates of men who have sex with men in the United States.
    AIDS. 2021;35.
    >> Share

  149. LI Z, Qiao S, Jiang Y, Li X, et al
    Building a social media-based HIV risk behavior index to inform the prediction of HIV new diagnosis: a feasibility study.
    AIDS. 2021;35.
    >> Share

  150. ZHENG C, Wang W, Young SD
    Identifying HIV-related digital social influencers using an iterative deep learning approach.
    AIDS. 2021;35.
    >> Share

  151. WANG B, Liu F, Deveaux L, Ash A, et al
    Adolescent HIV-related behavioural prediction using machine learning: a foundation for precision HIV prevention.
    AIDS. 2021;35.
    >> Share

  152. ZENG C, Zhang J, Sun X, Li Z, et al
    County-level predictors of retention in care status among people living with HIV in South Carolina from 2010 to 2016: a data-driven approach.
    AIDS. 2021;35.
    >> Share

  153. YANG X, Zhang J, Chen S, Weissman S, et al
    Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach.
    AIDS. 2021;35.
    >> Share

  154. CHEN S, Owolabi Y, Dulin M, Robinson P, et al
    Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA.
    AIDS. 2021;35.
    >> Share

  155. OLATOSI B, Sun X, Chen S, Zhang J, et al
    Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina.
    AIDS. 2021;35.
    >> Share

  156. WEISSMAN S, Yang X, Zhang J, Chen S, et al
    Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis.
    AIDS. 2021;35.
    >> Share

  157. OLATOSI B, Vermund SH, Li X
    Power of Big Data in ending HIV.
    AIDS. 2021;35.
    >> Share

  158. HASSOLD N, Baltes V, Martin A, Mechai F, et al
    Hemorrhagic cystitis from BK virus in a patient with AIDS.
    AIDS. 2021;35:999-1001.
    >> Share

    April 2021
  159. BROUILLETTE MJ, Koski L, Forcellino L, Gasparri J, et al
    Predicting occupational outcomes from neuropsychological test performance in older people with HIV.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96417.
    >> Share

  160. HUNG R, Patel N, Fox J, Cosgrove C, et al
    Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96416.
    >> Share

  161. MCCANN K, Shah S, Hindley L, Hill A, et al
    Implications of weight gain with newer antiretrovirals: 10-year predictions of cardiovascular disease and diabetes.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96415.
    >> Share

  162. DIRAJLAL-FARGO S, Sattar A, Yu J, Albar Z, et al
    Lipidome Association with Vascular Disease and Inflammation in HIV+ Ugandan Children.
    AIDS. 2021 Apr 19. pii: 00002030-900000000-96419.
    >> Share

  163. SLAMA L, Barrett BW, Abraham AG, Palella FJ Jr, et al
    Risk for incident diabetes is greater in pre-diabetic men with HIV than without HIV.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96422.
    >> Share

  164. SHITOLE SG, Lazar JM, Hanna DB, Kim RS, et al
    HIV, HCV and risk of new-onset left ventricular dysfunction: the women's interagency HIV study.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96421.
    >> Share

  165. LAU JSY, McMahon JH, Gubser C, Solomon A, et al
    The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96420.
    >> Share

  166. KALMIN MM, Westreich D, Drummond BM, Sun J, et al
    Incident obstructive lung disease and mortality among HIV-positive and negative persons with a history of injecting drugs.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96436.
    >> Share

  167. SANDAMANN L, Stoll M, Behrens GMN
    Hypophosphatemia in people living with HIV: No benefit when switching from TDF to TAF.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96435.
    >> Share

  168. SEKABIRA R, Mcgowan I, Yuhas K, Brand RM, et al
    Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96434.
    >> Share

  169. JENNESS SM, Knowlton G, Smith DK, Marcus JL, et al
    A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96433.
    >> Share

  170. GIANOTTI N, Galli L, Poli A, Torre LD, et al
    Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96432.
    >> Share

  171. SADOUNI M, Durand M, Boldeanu I, Danielli C, et al
    Association of Epicardial Fat with Non-Calcified Coronary Plaque Volume and With Low Attenuation Plaque in People Living with HIV.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96431.
    >> Share

  172. KARIUKI SM, Selhorst P, Abrahams MR, Rebe K, et al
    Neutralization sensitivity of genital tract HIV-1: shift in selective milieu shapes the population available to transmit.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96430.
    >> Share

  173. BASTARD JP, Pelloux V, Alili R, Fellahi S, et al
    Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir/maraviroc.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96429.
    >> Share

  174. APORNPONG T, Grinsztejn B, Hughes M, Ritz J, et al
    Antiretroviral Hair Levels, Self-Reported Adherence and Virologic Failure in Second-Line Regimen Patients in Resource-Limited Settings.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96428.
    >> Share

  175. MACBRAYNE CE, Rutstein RM, Wiznia AA, Graham B, et al
    Etravirine in treatment-experienced HIV-1 infected children 1-<6 years of age.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96427.
    >> Share

  176. FEINSTEIN MJ, Haberlen SA, Ashikaga H, Palella FJ, et al
    Ventricular ectopy and arrhythmia by HIV serostatus, viremia, and CD4+ cell count.
    AIDS. 2021;35:846-849.
    >> Share

  177. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.
    >> Share

  178. DRAK D, Dahwa R, Reakes E, Heron JE, et al
    Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy.
    AIDS. 2021;35:843-845.
    >> Share

  179. IKUMI NM, Malaba TR, Pillay K, Cohen MC, et al
    Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women.
    AIDS. 2021;35:717-726.
    >> Share

  180. STECHER C, Linnemayr S
    Promoting antiretroviral therapy adherence habits: a synthesis of economic and psychological theories of habit formation.
    AIDS. 2021;35:711-716.
    >> Share

    March 2021
  181. FRANCO S, Buccione D, Tural C, Martinez MA, et al
    Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96441.
    >> Share

  182. BERGLOV A, Moseholm E, Katzenstein TL, Johansen IS, et al
    Prevalence and association with birth outcomes of low Vitamin D levels among pregnant women living with HIV.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96440.
    >> Share

  183. MORGELLO S, Cortes EP, Gensler G, Meloni G, et al
    HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96439.
    >> Share

  184. RAVA M, Bisbal O, Dominguez-Dominguez L, Aleman MR, et al
    Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96438.
    >> Share

  185. MAXI JK, Foret BL, Amedee A, Mcdaniel LS, et al
    ART administration reduces neuroinflammation without restoring BDNF signaling in alcohol-administered SIV-infected macaques.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96437.
    >> Share

  186. COLLINS LF, Shantha JG, Nesper PL, Sheth AN, et al
    Assessment of retinal microvascular health by optical coherence tomography angiography among persons with HIV.
    AIDS. 2021 Mar 23. pii: 00002030-900000000-96442.
    >> Share

  187. GROVE M, Brown LL, Knudsen HK, Martin EG, et al
    Employing telehealth within HIV care: Advantages, challenges, and recommendations.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96447.
    >> Share

  188. LIN SH, Wang Y, Hartley SW, Karyadi DM, et al
    In utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96446.
    >> Share

  189. SMITH T, Masciotra S, Luo W, Sullivan V, et al
    Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96445.
    >> Share

  190. LAKE JE, LA K, Erlandson KM, Adrian S, et al
    Tesamorelin Improves Fat Quality Independent of Changes in Fat Quantity.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96444.
    >> Share

  191. TRAN H, Saleem K, Lim M, Chow EPF, et al
    Global estimates for the lifetime cost of managing HIV: a systematic review.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96443.
    >> Share

  192. JAO J, Jacobson DL, Russell JS, Wang J, et al
    Perinatally acquired HIV infection is associated with abnormal blood mitochondrial function during childhood/adolescence.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96451.
    >> Share

  193. CUTRELL AG, Schapiro JM, Perno CF, Kuritzkes DR, et al
    Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis across three phase 3 studies.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96450.
    >> Share

  194. CLUVER L, Shenderovich Y, Toska E, Rudgard WE, et al
    Clinic and care: associations with adolescent ART adherence in a prospective cohort in South Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96449.
    >> Share

  195. NGUYEN PT, Gilmour S, Le PM, Onishi K, et al
    Progress toward HIV elimination goals: trends in and projections of Annual HIV testing and condom use in Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96448.
    >> Share

  196. BUTEL-SIMOES G, Woolley I, McMahon J, Yeo A, et al
    IgG4-related disease masquerading as a fungating groin lesion in a patient with HIV and incomplete immune reconstitution.
    AIDS. 2021;35:706-707.
    >> Share

  197. HIREMATH PM, Suri D, Arora K, Shandilya J, et al
    Human leukocyte antigen B27 and B57 alleles in HIV-infected long-term nonprogressor children.
    AIDS. 2021;35:703-705.
    >> Share

  198. AGWU AL, Flynn PM
    Increasing the urgency to identify adolescents and young adults with HIV infection...do or die.
    AIDS. 2021;35:693-695.
    >> Share

  199. LURAIN K, Mbulaiteye SM
    Does HIV undermine breast cancer outcomes in women?
    AIDS. 2021;35:689-690.
    >> Share

  200. KOJIMA N, Klausner JD
    Preexposure prophylaxis is effective on a national level, but is it enough.
    AIDS. 2021;35:691-692.
    >> Share

  201. METSU D, Aquilina C, Delobel P, Gandia P, et al
    Maraviroc exposure is influenced by exogenous thyrotoxicosis.
    AIDS. 2021;35:701-703.
    >> Share

  202. PETT SL, Spyer M, Haddow LJ, Nhema R, et al
    Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
    AIDS. 2021;35:585-594.
    >> Share

  203. DALEL J, Ung SK, Hayes P, Black SL, et al
    HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96472.
    >> Share

  204. THIMM MA, Eke AC
    Tenofovir, pregnancy and renal function changes in pregnant women living with HIV.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96471.
    >> Share

  205. DEJONG C, Spinelli MA, Okochi H, Gandhi M, et al
    Tenofovir-based PrEP for COVID-19: an untapped opportunity?
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96470.
    >> Share

  206. BULSTRA CA, Reddy CL, Atun R, Barnighausen T, et al
    Impact of the COVID-19-related global recession on the financing of the global HIV response.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96469.
    >> Share

  207. FRENCH AL, Grennan D, Daubert E, Seaberg EC, et al
    Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/HCV co-infected women.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96468.
    >> Share

  208. NICKOLAS TL, Barasch J, Mugwanya KK, Branch AD, et al
    Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96467.
    >> Share

  209. MERCURIO V, Fitzgerald W, Vanpouille C, Molodtsov I, et al
    Mechanisms of residual immune activation in HIV-1 infected human lymphoid tissue ex vivo.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96466.
    >> Share

  210. TAKAHASHI N, Ardeshir A, Holder GE, Cai Y, et al
    Comparison of predictors for terminal disease progression in SIV/SHIV-infected rhesus macaques.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96465.
    >> Share

  211. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96464.
    >> Share

  212. KAPETANOVIC S, Giganti MJ, Abzug MJ, Lindsey JC, et al
    Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96463.
    >> Share

  213. WANG Z, Manion MM, Laidlaw E, Rupert A, et al
    Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96458.
    >> Share

  214. MOUNZER K, Brunet L, Wyatt CM, Fusco JS, et al
    To dose-adjust or not to dose-adjust: 3TC dose in kidney impairment.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96461.
    >> Share

  215. TAPIA GR, Glynn TR, Miller C, Manuzak JA, et al
    Syndemics and pre-exposure prophylaxis are independently associated with rectal immune dysregulation in sexual minority men.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96460.
    >> Share

  216. CONNOLLY S, Carlson JM, Schaefer M, Bere A, et al
    HLA-associated preadaptation in HIV Vif is associated with higher set point viral load and faster CD4 decline in Zambian transmission pairs.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96459.
    >> Share

  217. MORTON T, Chege W, Swann E, Senn TE, et al
    Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioral science: NIH workshop directions.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96457.
    >> Share

  218. VAN DEN HOF M, Jellema PEJ, Haar AMT, Scherpbier HJ, et al
    Normal structural brain development in adolescents treated for perinatally acquired HIV: A longitudinal imaging study.
    AIDS. 2021 Mar 8. pii: 00002030-900000000-96462.
    >> Share


  219. A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India: Erratum.
    AIDS. 2021;35:527.
    >> Share

  220. LUO G, Su L, Hu X, Lin YF, et al
    The role of e-commerce platforms in optimizing the HIV care continuum.
    AIDS. 2021;35:521-522.
    >> Share

  221. VANCE DE, Brew BJ
    HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
    AIDS. 2021;35:511-513.
    >> Share

  222. RIOS A
    Kaposi sarcoma: a fresh look.
    AIDS. 2021;35:515-516.
    >> Share

  223. ALDREDGE A, Roth G, Vaidya A, Paula Duarte A, et al
    Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia.
    AIDS. 2021;35:524-526.
    >> Share

  224. CATTANEO D, Vinti P, Baldelli S, Fusi M, et al
    Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.
    AIDS. 2021;35:522-524.
    >> Share

    February 2021
  225. DE FRANCESCO D, Sabin CA, Winston A, Mallon PWG, et al
    Agreement between self-reported and objective measures of sleep in people with HIV and lifestyle-similar HIV-negative individuals.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96476.
    >> Share

  226. MCCLUSKEY SM, Kamelian K, Musinguzi N, Kigozi S, et al
    Pre-treatment integrase inhibitor resistance is uncommon in ART-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96475.
    >> Share

  227. GUARALDI G, Calza S, Milic J, Calcagno A, et al
    Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96474.
    >> Share

  228. LI Y, Etemad B, Dele-Oni R, Sharaf R, et al
    Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96478.
    >> Share

  229. JAN AK, Moore JV, Wang RJ, Mcging M, et al
    Markers of inflammation and immune activation are associated with lung function in a multicenter cohort of persons with HIV.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96477.
    >> Share

  230. FALADE-NWULIA O, Seaberg EC, Snider AE, Rinaldo CR, et al
    Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96487.
    >> Share

  231. HAYS AG, Schar M, Barditch-Crovo P, Bagchi S, et al
    A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96486.
    >> Share

  232. HOLT M, Broady TR, Mao L, Chan C, et al
    Increasing pre-exposure prophylaxis use and 'net prevention coverage' in behavioural surveillance of Australian gay and bisexual men, 2014-19.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96485.
    >> Share

  233. KIMMEL SD, Walley AY, Lodi S, Forman LS, et al
    Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96484.
    >> Share

  234. HATCHER AM, Brittain K, Phillips TK, Zerbe A, et al
    Longitudinal association between intimate partner violence and viral suppression during pregnancy and postpartum in South African women.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96483.
    >> Share

  235. NELSON M, Winston A, Hill A, Mngqibisa R, et al
    Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96482.
    >> Share

  236. MOODLEY Y, Tomita A, de Oliveira T, Tanser F, et al
    HIV viral load and pregnancy loss: Results from a population-based cohort study in rural KwaZulu-Natal, South Africa.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96481.
    >> Share

  237. SHIAU S, Brummel SS, Kennedy EM, Hermetz K, et al
    Longitudinal changes in epigenetic age in youth with perinatally-acquired HIV and youth who are perinatally HIV-exposed uninfected.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96480.
    >> Share

  238. EKENBERG C, Reekie J, Zucco AG, Murray DD, et al
    The association of HLA alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96479.
    >> Share

  239. YANG FN, Bronshteyn M, Flowers SA, Dawson M, et al
    Low CD4 nadir exacerbates the impacts of APOE epsilon4 on functional connectivity and memory in adults with HIV.
    AIDS. 2021 Feb 5. pii: 00002030-900000000-96491.
    >> Share

  240. LUPO J, Germi R, Lancar R, Algarte-Genin M, et al
    Prospective evaluation of blood Epstein Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas.
    AIDS. 2021 Feb 5. doi: 10.1097/QAD.0000000000002839.
    >> Share

  241. MELLOR MM, Bast AC, Jones NR, Roberts NW, et al
    Risk of adverse COVID-19 outcomes for people living with HIV: a rapid review and meta-analysis.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96494.
    >> Share

  242. ZOU W, Xing J, Wang F, Chen X, et al
    HIV-1LAI Nef blocks the development of hematopoietic stem/ progenitor cells into T lymphoid cells.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96493.
    >> Share

  243. ROTHAN C, Yero A, Shi T, Farnos O, et al
    ART-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96492.
    >> Share

  244. HAMZAH L, Post FA
    Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravir.
    AIDS. 2021;35:349-351.
    >> Share

  245. ROTHERAM-BORUS MJ, Wynn A, Stewart J, Almirol E, et al
    Outcomes of HIV-exposed but uninfected children in South Africa over 5 years.
    AIDS. 2021;35:347-349.
    >> Share

  246. JOSEPH DAVEY DL, de Villiers L, Evens E
    Importance of rigorous implementation science studies to scale-up evidence-based interventions to end the HIV epidemic in the United States.
    AIDS. 2021;35:335-336.
    >> Share

  247. MOYO F, Mazanderani AH, Murray T, Sherman GG, et al
    Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa.
    AIDS. 2021;35:307-316.
    >> Share

  248. SALVATORE PP, de Broucker G, Vojnov L, Moss WJ, et al
    Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
    AIDS. 2021;35:287-297.
    >> Share

  249. MCENTIRE CRS, Fong KT, Jia DT, Cooper ER, et al
    Central nervous system disease with JC virus infection in adults with congenital HIV.
    AIDS. 2021;35:235-244.
    >> Share

  250. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    >> Share

  251. CAZZANIGA A, Scrimieri R, Galli M, Maier J, et al
    Unveiling the basis of antiretroviral therapy-induced osteopenia: the effects of Dolutegravir, Darunavir and Atazanavir on osteogenesis.
    AIDS. 2021;35:213-218.
    >> Share

  252. WANG Y, Lin X, Wen Y
    Organizing pneumonia-presenting acute respiratory distress syndrome because of paradoxical tuberculosis-immune reconstitution disease?
    AIDS. 2021;35:351-354.
    >> Share

    January 2021
  253. WANG L, Moqueet N, Simkin A, Knight J, et al
    Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96503.
    >> Share

  254. MADEDDU G, De Vito A, Cozzi-Lepri A, Cingolani A, et al
    Time spent with viral load
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96502.
    >> Share

  255. OLIVEIRA NL, Kennedy EH, Tibshirani R, Levine A, et al
    Longitudinal 5-year prediction of cognitive impairment among men with HIV disease.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96501.
    >> Share

  256. MUCCINI C, Galli L, Poli A, Godino C, et al
    Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96500.
    >> Share

  257. GEBREBRHAN H, Kambaran C, Sivro A, Adhiambo W, et al
    Rectal microbiota diversity in Kenyan men who have sex with men (MSM) is inversely associated with frequency of receptive anal sex, independent of HIV status.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96499.
    >> Share

  258. CHAN P, Kerr SJ, Kroon E, Colby D, et al
    Cognitive trajectories after treatment in acute HIV infection.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96498.
    >> Share

  259. NYAKATO P, Schomaker M, Sipambo N, Technau KG, et al
    Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa.
    AIDS. 2021 Jan 21. pii: 00002030-900000000-96504.
    >> Share

  260. ARANTES I, Bello G, Darcissac E, Lacoste V, et al
    Using phylogenetic surveillance and epidemiological data to understand the HIV-1 transmission dynamics in French Guiana.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96506.
    >> Share

  261. JOHNSTON PI, Wright SW, Orr M, Pearce FA, et al
    Worldwide relative smoking prevalence among people living with and without HIV: a systematic review and meta-analysis.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96505.
    >> Share

  262. BYONANEBYE DM
    Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96508.
    >> Share

  263. KANG R, Li J, Chen H, Tang Z, et al
    Using longitudinal genetic-network study to understand HIV treatment-as-prevention: a population-based observational study.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96507.
    >> Share

  264. LIU FF, Hall V, Cronin KM, Nair AP, et al
    'Peeling back the onion layers': the challenge of HIV-associated multicentric Castleman's disease.

    AIDS. 2021;35:159-161.
    >> Share

  265. ASHOK A, Hoy J, Spelman D, McMahon J, et al
    Successful treatment of disseminated Mycobacterium simiae infection in a patient with advanced HIV.
    AIDS. 2021;35:157-158.
    >> Share

  266. TRAEGER MW, Patel P, Guy R, Hellard ME, et al
    Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions.
    AIDS. 2021;35:155-157.
    >> Share

  267. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2021;35:151-154.
    >> Share

  268. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    AIDS. 2021;35:53-62.
    >> Share

    December 2020
  269. LAM JO, Hou CE, Hojilla JC, Anderson AN, et al
    Comparison of dementia risk after age 50 between individuals with and without HIV infection.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  270. BRANDAO M, Bruzzone M, Franzoi MA, de Angelis C, et al
    Impact of HIV infection on baseline characteristics and survival of women with breast cancer: a systematic review and meta-analysis.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  271. RITTENHOUSE KJ, Mwape H, Nelson JA, Mwale J, et al
    Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  272. NTHOBATSANG K, Ncenga TL, Mwangi-Woto C, Wedu TJ, et al
    Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  273. BUDD A, Krentz HB, Rubin LH, Power C, et al
    Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  274. NGONGO NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, et al
    Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  275. TORDOFF DM, Buskin S, Lechtenberg R, Golden MR, et al
    Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents of King County, Washington.
    AIDS. 2020 Dec 10. doi: 10.1097/QAD.0000000000002783.
    >> Share

  276. KIMURA CMS, Nahas CSR, Silva-Filho EV, Ribeiro VL, et al
    High-risk HPV test in anal smears: can it optimize the screening for anal cancer?
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002795.
    >> Share

  277. HICKEY MD, Imbert E, Glidden DV, Rosario JBD, et al
    Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002793.
    >> Share

  278. MOCROFT A
    The relationship between smoking, current CD4, viral load and cancer in persons living with HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002791.
    >> Share

  279. FALASCA K, Lanuti P, Ucciferri C, Pieragostino D, et al
    Circulating extracellular vesicles as new inflammation marker in hiv infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002794.
    >> Share

  280. HANDOKO R, Chan P, Jagodzinski L, Pinyakorn S, et al
    Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002786.
    >> Share

  281. MU W, Sharma M, Heymans R, Ritou E, et al
    ApoA-I mimetics attenuate macrophage activation in chronic treated HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002785.
    >> Share

  282. XIANG Y, Fujimoto K, Li F, Wang Q, et al
    Identifying influential neighbors in social networks and venue affiliations among young MSM: A data science approach to predict HIV infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002784.
    >> Share

  283. FIORENTINO M, Eubanks A, Coulaud PJ, Couderc C, et al
    Homonegativity, sexual violence and condom use with women in men who have sex with men and women in West Africa (CohMSM).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002782.
    >> Share

  284. ESTCOURT C, Yeung A, Nandwani R, Goldberg D, et al
    Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM.
    AIDS. 2020 Dec 7. doi: 10.1097/QAD.0000000000002790.
    >> Share

  285. BAILEY JV, Wayal S, Aicken CRH, Webster R, et al
    Interactive digital interventions for prevention of sexually transmitted HIV: systematic review and meta-analyses.
    AIDS. 2020 Dec 4. doi: 10.1097/QAD.0000000000002780.
    >> Share

  286. ONG JJ, Chow EPF, Read D, Taj U, et al
    Nudgeathons to control HIV: designing strategies using behavioural economics.
    AIDS. 2020;34:2337-2340.
    >> Share

  287. AVDOSHINA V, Mocchetti I
    HIV-associated neurodegenerative disorders: extracellular and intracellular mechanisms.
    AIDS. 2020;34:2334-2336.
    >> Share

  288. ZHAO T
    HIV-associated neurodegenerative disorders: role of endoplasmic reticulum in Gp120-mediated neurotoxicity.
    AIDS. 2020;34:2333-2334.
    >> Share

  289. VINIKOOR MJ, Hachaambwa L
    Advanced HIV disease during the 'Treat All' era in Botswana.
    AIDS. 2020;34:2321-2323.
    >> Share

  290. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    AIDS. 2020;34:2295-2304.
    >> Share

  291. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing.
    AIDS. 2020;34:2201-2210.
    >> Share

  292. ABRAHAMS N, Mhlongo S, Dunkle K, Chirwa E, et al
    Increase in HIV incidence in women exposed to rape: a comparative cohort study.
    AIDS. 2020 Dec 1. doi: 10.1097/QAD.0000000000002779.
    >> Share

  293. WOOD BR
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy.
    AIDS. 2020;34:2319-2320.
    >> Share

    November 2020
  294. MARTY L, Lemsalu L, Kivite-Urtane A, Costagliola D, et al
    Revealing HIV epidemic dynamics and contrasting responses in two WHO Eastern European countries: insights from modeling and data triangulation.
    AIDS. 2020 Nov 30. doi: 10.1097/QAD.0000000000002778.
    >> Share

  295. SEYEDALINAGHI S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, et al
    HIV in Iran: onset, responses and future directions.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002757.
    >> Share

  296. XIA Y, Milwid RM, Godin A, Boily MC, et al
    Accuracy of self-reported HIV testing history and awareness of HIV-positive status among people living with HIV in four Sub-Saharan African countries.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002759.
    >> Share

  297. SUNDERMANN EE, Fields A, Saloner R, Gouaux B, et al
    The utility of olfactory function in distinguishing early stage Alzheimer's disease from HIV-associated neurocognitive disorder.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002761.
    >> Share

  298. MCFALL AM, Lau B, Latkin C, Srikrishnan AK, et al
    Optimizing respondent driven sampling to find undiagnosed HIV-infected people who inject drugs.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002763.
    >> Share

  299. ROSEBUSH JC, Best BM, Chadwick EG, Butler K, et al
    Pharmacokinetics and safety of maraviroc in neonates.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002762.
    >> Share

  300. TREVILLYAN JM, Dart A, Paul E, Cavassini M, et al
    Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk; a randomised, controlled trial.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002764.
    >> Share

  301. DESMONDE S, Ciaranello AL, Malateste K, Musick B, et al
    Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus non-perinatally-acquired HIV.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002765.
    >> Share

  302. HUAMAN MA, Juchnowski SM, Zidar DA, Kityo CM, et al
    Monocyte activation in persons living with HIV and tuberculosis coinfection.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002766.
    >> Share

  303. BROOKS KM, Momper JD, Pinilla M, Stek AM, et al
    Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002767.
    >> Share

  304. COOLEY SA, Paul RH, Strain JF, Boerwinkle A, et al
    Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002768.
    >> Share

  305. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Maintenance of statin therapy among people living with HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002769.
    >> Share

  306. GROENE EA, Valeris-Chacin RJ, Stadelman AM, Safo SE, et al
    Maternal HIV and child anthropometric outcomes over time: An analysis of Zimbabwe demographic health surveys from 2005-2015.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002772.
    >> Share

  307. BAKER JV, Wolfson J, Collins G, Morse C, et al
    Losartan to reduce inflammation and fibrosis endpoints in HIV disease (LIFE-HIV): results from a randomized placebo-controlled trial.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002773.
    >> Share

  308. ZEZIULIN O, Mollan KR, Shook-Sa BE, Hanscom B, et al
    Depressive symptoms and use of HIV care and medication-assisted treatment among people living with HIV who inject drugs.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002774.
    >> Share

  309. TSHIKUNG ON, Smit M, Marinosci A, Buvelot H, et al
    Caring for people living with HIV during the global COVID-19 pandemic.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002775.
    >> Share

  310. GARCIA M, Morcilla V, Navarrete-Munoz MA, Fisher K, et al
    HIV-DNA Content in pTfh Cells is Associated with Residual Viremia in Elite Controllers.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002776.
    >> Share

  311. VELLOZA J, Kapogiannis B, Bekker LG, Celum C, et al
    Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth PrEP services?
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002777.
    >> Share

  312. ERLANDSON KM, Wu K, Lake JE, Samuels DC, et al
    Mitochondrial DNA haplogroups and weight gain following switch to INSTI-Based ART.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002771.
    >> Share

  313. HUGHES K, Chang J, Stadtler H, Wyatt C, et al
    HIV-1 infection of the kidney: mechanisms and implications.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002753.
    >> Share

  314. CHOW FC, Ma Y, Manion M, Rupert A, et al
    Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002755.
    >> Share


  315. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases Consensus panel: Erratum.
    AIDS. 2020;34:2161-2163.
    >> Share


  316. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients: Erratum.
    AIDS. 2020;34:2159.
    >> Share

  317. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020;34:2152-2155.
    >> Share

  318. SOUDEYNS H, Dumond J
    Unexpectedly low levels of transplacental transfer of second-generation integrase strand transfer inhibitors bictegravir and cabotegravir.
    AIDS. 2020;34:2137-2139.
    >> Share

  319. LEVY JA, Coutinho RA, Saag MS
    AIDS new editor announcement.
    AIDS. 2020;34:1995.
    >> Share

  320. FARR ZUEND C, Noel-Romas L, Hoger S, Mccorriser S, et al
    Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002751.
    >> Share

  321. BEDIMO RJ, Park LS, Shebl F, Sigel K, et al
    Statin exposure and risk of cancer in people with and without HIV infection.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002748.
    >> Share

  322. SEVERIN D, Faiza B, Nadia M, Aurelie DT, et al
    Kaposi sarcoma in people living with HIV: a comparative study of classic and HIV-viremic and aviremic AIDS Kaposi Sarcoma.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002744.
    >> Share

  323. ADAMS JW, Khan MR, Bessey SE, Friedman SR, et al
    Pre-exposure prophylaxis (PrEP) strategies for African American Women Affected by Mass Incarceration: A Modeling Study.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002749.
    >> Share

  324. REIN SM, Lampe FC, Johnson MA, Bhagani S, et al
    All-cause hospitalisation according to demographic group in people living with HIV in the current ART era: Recent findings from a cohort study in the UK.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002750.
    >> Share

  325. NICHOLS BE, Cele R, Jamieson L, Long LC, et al
    Community-based delivery of HIV treatment in Zambia: costs and outcomes.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002737.
    >> Share

  326. COLLINS LF, Colasanti JA, Nguyen ML, Moran CA, et al
    The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002746.
    >> Share

  327. PASVOL TJ, Teh J, Balfoussia D, Hall R, et al
    Outcomes of fertility investigations in a cohort of adults with perinatally acquired HIV-1 infection: a UK cross-sectional observational study.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002745.
    >> Share

  328. TAGO A, McKinnon LR, Wanjiru T, Muriuki F, et al
    Declines in HIV prevalence in female sex workers (FSWs) accessing an HIV treatment and prevention programme in Nairobi, Kenya over a 10-year period.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002747.
    >> Share


  329. Assessing the validity of and factors that influence accurate self-reporting of HIV status after testing: a population-based study: Erratum.
    AIDS. 2020;34:1993.
    >> Share

  330. GREEN M
    A letter to a young HIV doctor.
    AIDS. 2020;34:1991-1992.
    >> Share

  331. GABUZDA D, McArthur JC, Letendre SL
    Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system.
    AIDS. 2020;34:1975-1977.
    >> Share

  332. PYRA M, Rusie L, Castro M, Keglovitz Baker K, et al
    A taxonomy of pragmatic measures of HIV preexposure prophylaxis use.
    AIDS. 2020;34:1951-1957.
    >> Share

  333. MILIC J, Menozzi V, Schepis F, Malagoli A, et al
    Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    AIDS. 2020;34:1915-1921.
    >> Share

  334. LO B
    Toward respectful research with Indigenous people.
    AIDS. 2020;34:1979-1981.
    >> Share

  335. ROELOFSEN EE, Wildenbeest S, Mollema FP, Burger DM, et al
    Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomy.
    AIDS. 2020;34:1989-1991.
    >> Share

    October 2020
  336. SUGAWARA S, Manickam C, Reeves RK
    TRIGGERED: could refocused cell signaling be key to NK cell-based HIV immunotherapeutics?
    AIDS. 2020 Oct 27. doi: 10.1097/QAD.0000000000002743.
    >> Share

  337. SHERMAN BT, Hu X, Singh K, Haine L, et al
    Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002738.
    >> Share

  338. CHANDIWANA NC, Chersich M, Venter WF, Akpomiemie G, et al
    Unexpected interactions between dolutegravir and folate: randomised trial evidence from South Africa.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002741.
    >> Share

  339. CHLOE O, Elion R, Thompson M, Rockstroh JK, et al
    Changes in weight and body mass index with first-line doravirine-based therapy: a pooled analysis of three randomized controlled trials.
    AIDS. 2020 Oct 13. doi: 10.1097/QAD.0000000000002725.
    >> Share

  340. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002730.
    >> Share

  341. TEMU TM, Zifodya JS, Polyak SJ, Wagoner J, et al
    Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002729.
    >> Share

  342. BAJEMA KL, Nance RM, Delaney JAC, Eaton E, et al
    Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002679.
    >> Share

  343. WHITEMAN A, Baugher A, Sionean C
    Assessing self-reported discrimination among men who have sex with men.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002711.
    >> Share

  344. LU D, Sun H, Yu J, Kuang YQ, et al
    Chemsex drugs regulate HIV infection and replication in immune cells: A vicious circle.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002708.
    >> Share

  345. KOHLI M, Moore DJ, Moore RC
    Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002726.
    >> Share

  346. GILMORE JC, Serghides L, Bendayan R
    Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002707.
    >> Share

  347. DES JARLAIS DC, Duong Thi H, Khuat Thi Hai O, Feelemyer JP, et al
    Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002712.
    >> Share

  348. ROURKE SB, Bekele T, Rachlis A, Kovacs C, et al
    Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002709.
    >> Share

  349. AUDET CM, Ngobeni S, Mkansi M, Wafawanaka F, et al
    An unrecognized key population? traditional treatment practices associated with HIV risk among traditional healers in rural South Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002710.
    >> Share

  350. SHANGANI S, Bhaskar N, Richmond N, Operario D, et al
    A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002713.
    >> Share

  351. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of pre-exposure prophylaxis in the Netherlands - a mixed-methods analysis.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002714.
    >> Share

  352. SIBIUDE J, Le Chenadec J, Mandelbrot L, Dollfus C, et al
    Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002719.
    >> Share

  353. NJUGUNA IN, Wagner AD, Neary J, Omondi VO, et al
    Financial incentives to increase pediatric hiv testing: a randomized trial.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002720.
    >> Share

  354. CARLANDER C, Wagner P, Yilmaz A, Sparen P, et al
    Employment by HIV status, mode of HIV transmission and migrant status: a nation-wide population-based study with twenty years of follow-up.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002724.
    >> Share

  355. SHANAUBE K, Schaap A, Hoddinott G, Mubekapi-Musadaidzwa C, et al
    Impact of a community-wide combination HIV prevention intervention on knowledge of HIV status among adolescents.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002722.
    >> Share

  356. HSU R, Brunet L, Fusco JS, Mounzer K, et al
    Incident Type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002718.
    >> Share

  357. JONES CI, Rose SL, Shutt A, Cairo C, et al
    Maternal HIV status skews transcriptomic response in infant cord blood monocytes exposed to BCG.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002706.
    >> Share

  358. ZHANG J, Thakuri BKC, Zhao J, Nguyen LN, et al
    LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002700.
    >> Share

  359. HESSOL NA, Barrett BW, Margolick JB, Plankey M, et al
    Risk of smoking-related cancers among women and men living with and without hiv.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002717.
    >> Share

  360. WAGMAN JA, Wynn A, Matsuzaki M, Gnatienko N, et al
    Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002716.
    >> Share

  361. VONASEK B, Kay A, Devezin T, Bacha JM, et al
    Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002715.
    >> Share

  362. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a gag mutation that abrogates KIR binding and disinhibits NK cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002721.
    >> Share

  363. PILKINGTON V, Hughes SL, Pepperrell T, McCann K, et al
    Tenofovir alafenamide versus tenofovir disoproxil fumarate - an updated meta-analysis of 14,894 patients across 14 trials.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002699.
    >> Share

  364. MURAKOSHI H, Chikata T, Akahoshi T, Zou C, et al
    Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002704.
    >> Share

  365. SERRANO PA, Daubert E, Munoz A, Hosek SG, et al
    Effect of Truvada lawsuit advertising on PrEP attitudes and decisions among sexual and gender minority youth and young adults at risk for HIV.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002728.
    >> Share

  366. DI BIAGIO A, Taramasso L, Dentone C, Vena A, et al
    Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients?
    AIDS. 2020;34:1865-1867.
    >> Share

  367. CONWAY B
    Treatment of primary HIV infection: new data for a new era.
    AIDS. 2020;34:1855-1856.
    >> Share

  368. SANTOS ME, Protopopescu C, Ribero RA, Benzaken AS, et al
    Population attributable fractions of mortality in people living with HIV: roles of delayed antiretroviral therapy, hepatitis coinfections and social factors.
    AIDS. 2020;34:1843-1854.
    >> Share

  369. BENNETT SJ, Chunda-Liyoka C, Poppe LK, Meinders K, et al
    High nonnucleoside reverse transcriptase inhibitor resistance levels in HIV-1-infected Zambian mother-infant pairs.
    AIDS. 2020;34:1833-1842.
    >> Share

  370. CHARRE C, Icard V, Pradat P, Brochier C, et al
    Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis users.
    AIDS. 2020;34:1765-1770.
    >> Share

  371. PASTAKIA SD, Braitstein P, Galarraga O, Genberg B, et al
    Preserving 2 decades of healthcare gains for Africa in the coronavirus disease 2019 era.
    AIDS. 2020;34:1761-1763.
    >> Share

  372. SAAG M
    Special section: COVID-19 among people living with HIV.
    AIDS. 2020;34:1755-1756.
    >> Share

  373. MAI B, Wang W, Lin M, Hu S, et al
    HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients.
    AIDS. 2020;34:1735-1743.
    >> Share

  374. GRANT M
    Regulation of natural killer cells: analog peptide handshake goes digital.
    AIDS. 2020;34:1857-1858.
    >> Share

  375. EL-SADR WM
    What one pandemic can teach us in facing another.
    AIDS. 2020;34:1757-1759.
    >> Share

    September 2020
  376. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance Profile of Human Immunodeficiency Virus 1 (HIV-1) Quasispecies in Patients Under Treatment Failure Using Single Molecule, Real-Time (SMRT) Sequencing.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002697.
    >> Share

  377. LEVY JA
    The need to reassess our approaches at HIV cure and prevention.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002695.
    >> Share

  378. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002692.
    >> Share

  379. CHIAO E, Lensing SY, Wiley DJ, Deshmukh AA, et al
    Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002694.
    >> Share

  380. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    CSF viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002687.
    >> Share

  381. WILSON IB, Tie Y, Padilla M, Rogers WH, et al
    Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002689.
    >> Share

  382. BOUVIN-PLEY M, Leoz M, Roch E, Moreau A, et al
    Differential utilization of CD4 by transmitted/founder and chronic envelope glycoproteins in a MSM HIV-1 subtype B transmission cluster.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002690.
    >> Share

  383. YOTSUMOTO M, Hachiya A, Ichiki A, Amano K, et al
    Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002688.
    >> Share

  384. AMBROSIONI J, Farrera J, de Lazzari E, Nicolas D, et al
    Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002685.
    >> Share

  385. TELWATTE S, Kim P, Chen TH, Milush JM, et al
    Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002684.
    >> Share

  386. O'REILLY KR, Fonner VA, Kennedy CE, Yeh PT, et al
    The paradox of HIV prevention: did biomedical prevention trials show how effective behavioral prevention can be?
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002682.
    >> Share

  387. TSONDAI PR, Braithewaite K, Fatti G, Bolton-Moore C, et al
    Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002683.
    >> Share

  388. JENNESS SM, Johnson JA, Hoover KW, Smith DK, et al
    Modeling an integrated HIV prevention and care continuum to achieve the ending the HIV epidemic goals.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002681.
    >> Share

  389. FEELEMYER J, Arasteh K, Thi HD, Hai OKT, et al
    Associations between methamphetamine use and lack of viral suppression among a cohort of HIV positive persons who inject drugs in hai phong vietnam.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002680.
    >> Share

  390. MAHTAB S, Scott C, Asafu-Agyei NAA, Machemedze T, et al
    Prevalence and predictors of bone health among perinatally HIV-infected adolescents.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002686.
    >> Share

  391. BANDA FM, Powis KM, Sun S, Makhema J, et al
    Fetal biometry following in utero exposure to dolutegravir- or efavirenz-based antiretroviral therapy.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002674.
    >> Share

  392. AGRATI C, De Biasi S, Fidanza L, Gibellini L, et al
    The importance of advanced cytometry in defining new immune cell types and functions relevant for the immunopathogenesis of HIV infection.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002675.
    >> Share

  393. PUJARI S, Gugale P, Shah D, Patel D, et al
    Pulmonary Tuberculosis masquerading as COVID19 in an HIV infected individual with advanced immune suppression.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002676.
    >> Share

  394. SPINELLI MA, Hickey MD, Glidden DV, Nguyen JQ, et al
    Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002677.
    >> Share

  395. FUSCO FM, Sangiovanni V, Tiberio C, Papa N, et al
    Persons living with HIV may be reluctant to access to COVID-19 testing services: data from "D. Cotugno" hospital, naples, southern Italy.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002678.
    >> Share

  396. MOLINA-ITURRITZA E, San-Jose-Muniz I, Ganchegui-Aguirre M, Balerdi-Sarasola L, et al
    Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.
    AIDS. 2020;34:1696-1697.
    >> Share

  397. SASSET L, Di Meco E, Cavinato S, Cattelan AM, et al
    Coinfection of severe acute respiratory syndrome coronavirus 2 and HIV in a teaching hospital: still much to learn.
    AIDS. 2020;34:1694-1696.
    >> Share

  398. FREER J
    Human papilloma virus-related cancers: MSM and trans people living with HIV are still getting left behind.
    AIDS. 2020;34:1692-1694.
    >> Share

  399. GUNST JD, Schleimann MH, Pahus MH, Ostergaard L, et al
    HIV-1 acquisition in a man with ulcerative colitis on anti-alpha4beta7 mAb vedolizumab treatment.
    AIDS. 2020;34:1689-1692.
    >> Share

  400. BEDIMO RJ, Adams-Huet B, Nguyen V, Moore-Matthews D, et al
    Changes in bone microarchitecture with abacavir--lamivudine versus tenofovir disoproxil fumarate--emtricitabine in adults living with HIV.
    AIDS. 2020;34:1687-1689.
    >> Share

  401. CACHAY ER, Torriani FJ, Hill L, Jain S, et al
    The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV.
    AIDS. 2020;34:1681-1683.
    >> Share

  402. CHRISTOPOULOS KA, Neilands TB, Dilworth S, Lisha N, et al
    Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and antiretroviral therapy adherence.
    AIDS. 2020;34:1665-1671.
    >> Share

  403. DIRAJLAL-FARGO S, Yu J, Albar Z, Sattar A, et al
    Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction.
    AIDS. 2020;34:1615-1623.
    >> Share

  404. DHANDE JR, Saikia K, Singh DP, Bagul RD, et al
    Higher frequencies of functional HIV-envelope-specific memory B cells are associated with nonprogressive HIV infection in Indian population.
    AIDS. 2020;34:1603-1608.
    >> Share

  405. SIRAPRAPASIRI T, Srithanaviboonchai K, Chantcharas P, Suwanphatthana N, et al
    Integration and scale-up of efforts to measure and reduce HIV-related stigma: the experience of Thailand.
    AIDS. 2020;34 Suppl 1:S103-S114.
    >> Share

  406. NYBLADE L, Mbuya-Brown RJ, Ezekiel MJ, Addo NA, et al
    A total facility approach to reducing HIV stigma in health facilities: implementation process and lessons learned.
    AIDS. 2020;34 Suppl 1:S93-S102.
    >> Share

  407. SINGH RJ, Sarna A, Schensul JJ, Mahapatra B, et al
    A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India.
    AIDS. 2020;34 Suppl 1:S83-S92.
    >> Share

  408. YIGIT I, Modi RA, Weiser SD, Johnson MO, et al
    Effects of an intervention on internalized HIV-related stigma for individuals newly entering HIV care.
    AIDS. 2020;34 Suppl 1:S73-S82.
    >> Share

  409. LYONS CE, Olawore O, Turpin G, Coly K, et al
    Intersectional stigmas and HIV-related outcomes among a cohort of key populations enrolled in stigma mitigation interventions in Senegal.
    AIDS. 2020;34 Suppl 1:S63-S72.
    >> Share

  410. BROADY TR, Brener L, Hopwood M, Cama E, et al
    HIV stigma by association among Australian gay and bisexual men.
    AIDS. 2020;34 Suppl 1:S53-S62.
    >> Share

  411. YAM EA, Pulerwitz J, Almonte D, Garcia F, et al
    Stigma among key populations living with HIV in the Dominican Republic: experiences of people of Haitian descent, MSM, and female sex workers.
    AIDS. 2020;34 Suppl 1:S43-S52.
    >> Share

  412. GEIBEL S, Gottert A, Friedland BA, Jeremiah K, et al
    Internalized stigma among people living with HIV: assessing the Internalized AIDS-Related Stigma Scale in four countries.
    AIDS. 2020;34 Suppl 1:S33-S42.
    >> Share

  413. GOTTERT A, McClair TL, Pulerwitz J, Friedland BA, et al
    What shapes resilience among people living with HIV? A multi-country analysis of data from the PLHIV Stigma Index 2.0.
    AIDS. 2020;34 Suppl 1:S19-S32.
    >> Share

  414. FRIEDLAND BA, Gottert A, Hows J, Baral SD, et al
    The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide.
    AIDS. 2020;34 Suppl 1:S5-S18.
    >> Share

  415. SEELEY J, Blanc AK
    Reducing stigma and discrimination: new evidence and its implications.
    AIDS. 2020;34 Suppl 1:S1-S4.
    >> Share

    August 2020
  416. GOERLICH E, Mukherjee M, Schar M, Brown TT, et al
    Noninvasive detection of impaired pulmonary artery endothelial function in people living with HIV.
    AIDS. 2020 Aug 20. doi: 10.1097/QAD.0000000000002671.
    >> Share

  417. STRATHDEE SA, Kuo I, El-Bassel N, Hodder S, et al
    Preventing HIV outbreaks among people who inject drugs in the United States: Plus ca change, plus ca meme chose.
    AIDS. 2020 Aug 20. doi: 10.1097/QAD.0000000000002673.
    >> Share

  418. HADI YB, Naqvi SFZ, Kupec JT, Sarwari AR, et al
    Characteristics and outcomes of COVID-19 in patients with HIV: a multi-center research network study.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002666.
    >> Share

  419. ZANG X, Krebs E, Mah C, Min JE, et al
    Can the 'Ending the HIV Epidemic' initiative transition the US towards HIV/AIDS epidemic control?
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002668.
    >> Share

  420. PINEIRO F, Climent F, Imaz A, Gudiol C, et al
    Clinical and pathological features of kaposi sarcoma herpesvirus inflammatory cytokine syndrome: case report and review of the literature.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002669.
    >> Share

  421. DI BIAGIO A, Ricci E, Calza L, Squillace N, et al
    Factors associated with hospital admission for COVID-19 in HIV patients.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002663.
    >> Share

  422. D'ELBEE M, Makhetha MC, Jubilee M, Taole M, et al
    Using HIV self-testing to increase the affordability of community-based HIV testing services: A longitudinal analysis in Lesotho.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002664.
    >> Share

  423. BROCHADO-KITH O, Martinez I, Berenguer J, Medrano LM, et al
    Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002645.
    >> Share

  424. PENCOLE L, Le MP, Bouchet-Crivat F, Duro D, et al
    Placental Transfer of the integrase strand inhibitors cabotegravir and bictegravir in the Ex-Vivo Human Cotyledon Perfusion Model.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002637.
    >> Share

  425. ROSE R, Cross S, Lamers SL, Astemborski J, et al
    Persistence of HIV transmission clusters among people who inject drugs.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002662.
    >> Share

  426. REN M, Szadkowski L, Walmsley SL
    Deciphering the serological response to syphilis treatment in men living with HIV: do we meet the definitions for cure?
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002656.
    >> Share

  427. SABIN CA, Harding R, Bagkeris E, Geressu A, et al
    The predictors of pain extent in people living with HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002660.
    >> Share

  428. DEZANET LNC, Maylin S, Gabassi A, Rougier H, et al
    Correlation of serum hepatitis B core-related antigen with HBV total intrahepatic DNA and ccc-DNA viral load in HIV-hepatitis B coinfection.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002659.
    >> Share

  429. COUTIFARIS P, Byrd D, Childs J, Clark U, et al
    Neurobehavioral outcomes in young adults with perinatally-acquired HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002655.
    >> Share

  430. YUNIHASTUTI E, Teeratakulpisarn N, Jeo WS, Nilasari H, et al
    Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002654.
    >> Share

  431. SAAG M
    Editor's comment.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002648.
    >> Share

  432. ETIENNE N, Karmochkine M, Slama L, Pavie J, et al
    HIV infection and COVID-19: risk factors for severe disease.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002651.
    >> Share

  433. SHPONKA V, Reveles CY, Alam S, Jaramillo M, et al
    Frequent expression of activation induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002653.
    >> Share

  434. GAY CL, Neo DT, Devanathan AS, Kuruc JD, et al
    Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002652.
    >> Share

  435. MILIC J, Menozzi V, Schepis F, Malagoli A, et al
    Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002650.
    >> Share

  436. EVANS C, Chasekwa B, Rukobo S, Govha M, et al
    Inflammation, cytomegalovirus and the growth hormone axis in HIV-exposed uninfected Zimbabwean infants.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002646.
    >> Share

  437. INCIARTE A, Gonzalez-Cordon A, Rojas J, Torres B, et al
    Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002643.
    >> Share

  438. ASSOUMOU L, Racine C, Fellahi S, Lamaziere A, et al
    Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002644.
    >> Share

  439. STANGL AL, Pliakas T, Mainga T, Steinhaus M, et al
    The effect of universal testing and treatment on HIV stigma in 21 communities in Zambia and South Africa: results from a cluster randomised trial.
    AIDS. 2020 Aug 6. doi: 10.1097/QAD.0000000000002658.
    >> Share

  440. TOZZI B, Gavioli C, Linhares L, Entringer M, et al
    Pruritic papular eruption in HIV-positive patients in Brazil.
    AIDS. 2020;34:1576-1578.
    >> Share

  441. CHIRWA M, Mazzitelli M, Pereira B, Milinkovic A, et al
    Incidental findings in elderly people living with HIV undergoing computed tomography coronary artery calcium scoring.
    AIDS. 2020;34:1573-1575.
    >> Share

  442. LATINI A, Alei L, Magri F, Eibenschutz L, et al
    Nonmelanoma skin cancer and melanoma in HIV-1-infected patients.
    AIDS. 2020;34:1570-1572.
    >> Share

  443. INZAULE SC, Bertagnolio S, Kityo CM, Siwale M, et al
    The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.
    AIDS. 2020;34:1559-1566.
    >> Share

  444. CLOSSON K, McLinden T, Parry R, Lee M, et al
    Severe intimate partner violence is associated with all-cause mortality among women living with HIV.
    AIDS. 2020;34:1549-1558.
    >> Share

  445. LESKO CR, Chander G, Moore RD, Lau B, et al
    Variation in estimated viral suppression associated with the definition of viral suppression used.
    AIDS. 2020;34:1519-1526.
    >> Share

  446. MERCHANTE N, Rodriguez-Fernandez M, Figueruela B, Rodriguez-Arrondo F, et al
    Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients.
    AIDS. 2020;34:1497-1507.
    >> Share

  447. MOCROFT A, Ryom L, Oprea C, Li Q, et al
    Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
    AIDS. 2020;34:1485-1495.
    >> Share

  448. TITANJI K, Ofotokun I, Weitzmann MN
    Immature/transitional B-cell expansion is associated with bone loss in HIV-infected individuals with severe CD4+ T-cell lymphopenia.
    AIDS. 2020;34:1475-1483.
    >> Share

  449. PINACCHIO C, Scagnolari C, Iebba V, Santinelli L, et al
    High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.
    AIDS. 2020;34:1467-1473.
    >> Share

  450. GIRON LB, Azzoni L, Yin X, Lynn KM, et al
    Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals.
    AIDS. 2020;34:1461-1466.
    >> Share

  451. SAHBANDAR IN, Chew GM, Corley MJ, Pang APS, et al
    Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
    AIDS. 2020;34:1451-1460.
    >> Share

  452. KAHN J
    The changing HIV epidemic: a view from the front line in the United States.
    AIDS. 2020;34:1437-1438.
    >> Share

  453. SU J, Shen X, Ni Q, Zhao H, et al
    Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS.
    AIDS. 2020;34:1575-1576.
    >> Share

    July 2020
  454. WINSTON A, De Francesco D, Post F, Boffito M, et al
    Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002606.
    >> Share

  455. DIEPSTRA K, Lu H, McManus KA, Rogawski McQuade ET, et al
    What we talk about when we talk about durable viral suppression.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002612.
    >> Share

  456. CHRISTOPOULOS KA, Neilands TB, Dilworth S, Lisha N, et al
    Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and ART adherence.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002595.
    >> Share

  457. DIRAJLAL-FARGO S, Yu J, Albar Z, Sattar A, et al
    Monocyte activation and gut barrier dysfunction in South African youth on art and their associations with endothelial dysfunction.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002615.
    >> Share

  458. SANTOS ME, Protopopescu C, Ribeiro RA, Benzaken AS, et al
    Population attributable fractions of mortality in people living with HIV: roles of delayed ART, hepatitis coinfections and social factors.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002621.
    >> Share

  459. TOWNSEND SJ, Chunda-Liyoka C, Poppe LK, Meinders K, et al
    High NNRTI resistance levels in HIV-1 infected Zambian mother-infant pairs.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002614.
    >> Share

  460. BOBROW K, Xia F, Hoang T, Valcour V, et al
    HIV and risk of dementia in older veterans.
    AIDS. 2020 Jul 22. doi: 10.1097/QAD.0000000000002597.
    >> Share

  461. PASTAKIA SD, Braitstein P, Galarraga O, Genberg B, et al
    Preserving two decades of healthcare gains for africa in the Covid-19 era.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002605.
    >> Share

  462. GIATSOU E, Abdi B, Plu I, Desire N, et al
    Ultradeep sequencing reveals HIV-1 diversity and resistance compartmentalization during HIV-encephalopathy.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002616.
    >> Share

  463. KNETTEL BA, Mwamba RN, Minja L, Goldston DB, et al
    Exploring patterns and predictors of suicidal ideation among pregnant and postpartum women living with HIV in Kilimanjaro, Tanzania.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002594.
    >> Share

  464. SABO MC, Lehman DA, Pintye JC, Wang B, et al
    Elevation of Cervical CXCL10 Levels is Associated with HIV-1 Acquisition in Pregnant and Postpartum Women.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002613.
    >> Share

  465. CACHAY ER, Torriani FJ, Hill L, Jain S, et al
    The role of barriers to care on the propensity for HCV non-referral among people living with HIV.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002610.
    >> Share

  466. TSHIVUILA-MATALA C, Honeyman S, Nesbitt C, Kirtley S, et al
    Perinatal outcomes associated with antiretroviral therapy: systematic review and network meta-analysis of randomised controlled trials.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002593.
    >> Share

  467. TRUNFIO M, Rugge W, Mighetto L, Vai D, et al
    Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002601.
    >> Share

  468. MAI B, Wang W, Lin M, Hu S, et al
    HIV-Associated plasmablastic lymphoma in the era of highly active antiretroviral therapy: a single center experience of 21 patients.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002590.
    >> Share

  469. HUGHES K, Akturk G, Gnjatic S, Chen B, et al
    Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002589.
    >> Share

  470. WALL KM, Kilembe W, Inambao M, Hoagland A, et al
    Cost-effectiveness of integrated HIV prevention and family planning services for Zambian couples.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002584.
    >> Share

  471. CHARRE C, Icard V, Pradat P, Brochier C, et al
    COVID-19 attack rate in HIV-infected patients and in PrEP users.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002639.
    >> Share

  472. JONES DL, Alcaide VJR, Luisa M, Carrico A, et al
    Syndemic burden and systemic inflammation, HIV health status, and blood pressure among women with unsuppressed HIV viral loads in the Women's Interagency HIV Study.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002617.
    >> Share

  473. LANG R, Czarnecki C, Kim J, Luider J, et al
    Identification and root-cause analysis of aberrant CD4 counts in an HIV cohort; the importance of quality control in changing laboratory procedure.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002638.
    >> Share

  474. ABDI B, Nguyen T, Brouillet S, Desire N, et al
    No HIV-1 molecular evolution on long term antiretroviral therapy initiated during primary HIV-1 infection.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002629.
    >> Share

  475. PYRA M, Rusie L, Castro M, Baker KK, et al
    A taxonomy of pragmatic measures of HIV pre-exposure prophylaxis (PrEP) Use: application in a PrEP-using cohort in Chicago, IL.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002618.
    >> Share

  476. EGGERS C, Hoetelmans R, Laer S
    Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002626.
    >> Share

  477. MEDINA N, Alastruey-Izquierdo A, Mercado D, Bonilla O, et al
    Comparative performance of the laboratory assays used by a diagnostic laboratory hub for opportunistic infections in people living with HIV.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002631.
    >> Share

  478. DHANDE JR, Saikia K, Singh DP, Bagul RD, et al
    Higher frequencies of functional HIV-Envelope specific memory B cells are associated with non-progressive HIV infection in Indian population.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002620.
    >> Share

  479. FERRARA M, Bumpus NN, Ma Q, Ellis RJ, et al
    Antiretroviral drug concentrations in brain tissue of adult decedents.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002628.
    >> Share

  480. LEBELONYANE R, Mills LA, Mogorosi C, Ussery F, et al
    Advanced HIV disease in the botswana combination prevention project: prevalence, risk factors, and outcomes.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002627.
    >> Share

  481. BOESECKE C
    Recently acquired and early chronic hepatitis C in men having sex with men (MSM): Recommendations from the NEAT-ID consensus panel.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002622.
    >> Share

  482. INZAULE SC, Jordan MR, Cournil A, Giron-Callejas A, et al
    Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low- and middle-income countries.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002623.
    >> Share

  483. ADACHI E, Saito M, Ikeuchi K, Hoshina T, et al
    Cases of coronavirus disease-2019 in HIV-infected transgender women.
    AIDS. 2020;34:1435-1436.
    >> Share

  484. PROIETTI I, Skroza N, Michelini S, Mambrin A, et al
    Efficacy of nivolumab in HIV patient with melanoma brain metastases.
    AIDS. 2020;34:1433-1435.
    >> Share

  485. BERZKALNS AE, Barbee LA, Dombrowski JC, Golden MR, et al
    Low HIV incidence among women following sexually transmitted infection does not support national pre-exposure prophylaxis recommendations.
    AIDS. 2020;34:1429-1431.
    >> Share

  486. ALUFANDIKA M, Lawrence DS, Boyer-Chammard T, Kanyama C, et al
    A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
    AIDS. 2020;34:1425-1428.
    >> Share

  487. SAMPAIO JDA, Jacome-Santos H, Aires AV, Pinheiro JJV, et al
    Orofacial outcomes in adolescents with perinatally infected HIV in antiretroviral therapy.
    AIDS. 2020;34:1417-1423.
    >> Share

  488. CALVERT C, Marston M, Slaymaker E, Crampin AC, et al
    Direct maternal deaths attributable to HIV in the era of antiretroviral therapy: evidence from three population-based HIV cohorts with verbal autopsy.
    AIDS. 2020;34:1397-1405.
    >> Share

  489. LIANG J, Nosova E, Reddon H, Nolan S, et al
    Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    AIDS. 2020;34:1389-1396.
    >> Share

  490. LAM E, Hites M, Cantinieaux B, Van Laethem Y, et al
    Malaria in HIV-infected patients in a nonendemic setting.
    AIDS. 2020;34:1359-1365.
    >> Share

  491. HOSSEINI-HOOSHYAR S, Martinello M, Yee J, Read P, et al
    Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    AIDS. 2020;34:1347-1358.
    >> Share

  492. PATEL MR, Mushavi A, Balachandra S, Shambira G, et al
    HIV-exposed uninfected infant morbidity and mortality within a nationally representative prospective cohort of mother-infant pairs in Zimbabwe.
    AIDS. 2020;34:1339-1346.
    >> Share

  493. MWIMANZI F, Ngare I, Toyoda M, Mori M, et al
    An HIV-1 Nef genotype that diminishes immune control mediated by protective human leucocyte antigen alleles.
    AIDS. 2020;34:1325-1330.
    >> Share

  494. SHARMA V, Bryant C, Montero M, Creegan M, et al
    Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.
    AIDS. 2020;34:1289-1301.
    >> Share

  495. COLLINS LF, Moran CA, Oliver NT, Moanna A, et al
    Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA.
    AIDS. 2020 Jul 14. doi: 10.1097/QAD.0000000000002632.
    >> Share

  496. FEITERNA-SPERLING C, Bukkems VE, Teulen MJA, Colbers AP, et al
    Low raltegravir transfer into the breastmilk of a woman living with HIV.
    AIDS. 2020 Jul 14. doi: 10.1097/QAD.0000000000002624.
    >> Share

  497. COLEMAN H, Snell LB, Simons R, Douthwaite ST, et al
    Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV.
    AIDS. 2020;34:1258-1260.
    >> Share

  498. DI GIAMBENEDETTO S, Del Giacomo P, Ciccullo A, Porfidia A, et al
    SARS-CoV-2 infection in a highly experienced person living with HIV.
    AIDS. 2020;34:1257-1258.
    >> Share

  499. DAUBY N
    Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.
    AIDS. 2020;34:1255-1256.
    >> Share

  500. CATTANEO D, Minisci D, Formenti T, Negri C, et al
    The prescribing cascade 3.0: a case for recreational drugs in HIV.
    AIDS. 2020;34:1253-1255.
    >> Share

  501. BRENNER BG
    Phylogenetics: an added ingredient in HIV prevention.
    AIDS. 2020;34:1247-1248.
    >> Share

  502. NGUYEN N, Choi CJ, Robbins R, Korich R, et al
    Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.
    AIDS. 2020;34:1205-1215.
    >> Share

  503. YE L, Wang J, Teque F, Xie F, et al
    Generation of HIV-1-infected patients' gene-edited induced pluripotent stem cells using feeder-free culture conditions.
    AIDS. 2020;34:1127-1139.
    >> Share

  504. ODHIAMBO F, Mulwa E, Ayieko J, Kulzer J, et al
    Implementation of HIV care in Western Kenya during corona virus disease 2019 response.
    AIDS. 2020;34:F1-F2.
    >> Share

    June 2020
  505. MEYEROWITZ EA, Kim AY, Ard KL, Basgoz N, et al
    Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV.
    AIDS. 2020 Jun 25. doi: 10.1097/QAD.0000000000002607.
    >> Share

  506. STANKEVITZ K, Grant H, Lloyd J, Gomez GB, et al
    Oral pre-exposure prophylaxis (PrEP) continuation, measurement, and reporting: a systematic review and meta-analysis.
    AIDS. 2020 Jun 17. doi: 10.1097/QAD.0000000000002598.
    >> Share

  507. MASTRO TD, Akolo C, Shoptaw S
    Managing amphetamine use is critical to achieving HIV control.
    AIDS. 2020 Jun 16. doi: 10.1097/QAD.0000000000002611.
    >> Share

  508. BOUZIDI KEL, Jose S, Phillips AN, Pozniak A, et al
    First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines: a cohort study.
    AIDS. 2020 Jun 8. doi: 10.1097/QAD.0000000000002603.
    >> Share

  509. VAN HALSEMA CL, Okhai H, Hill T, Sabin CA, et al
    Incidence and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the UK.
    AIDS. 2020 Jun 4. doi: 10.1097/QAD.0000000000002599.
    >> Share

  510. ZIEGLER MC, Nelde A, Weber JK, Schreitmuller CM, et al
    HIV-1-induced changes in HLA-C*03: 04-presented peptide repertoires lead to reduced engagement of inhibitory NK cell receptors.
    AIDS. 2020 Jun 4. doi: 10.1097/QAD.0000000000002596.
    >> Share

  511. SAULLE I, Ibba SV, Vittori C, Fenizia C, et al
    Sterol metabolism modulates susceptibility to HIV-1 Infection.
    AIDS. 2020 Jun 4. doi: 10.1097/QAD.0000000000002591.
    >> Share

  512. THEPPOTE AS, Carmack AE, Riedel DJ
    False positive HIV testing after T-cell receptor therapy.
    AIDS. 2020;34:1103-1105.
    >> Share

  513. LI GH, Maric D, Major EO, Nath A, et al
    Productive HIV infection in astrocytes can be established via a nonclassical mechanism.
    AIDS. 2020;34:963-978.
    >> Share

  514. BROUILLETTE MJ, Fellows LK, Mayo NE
    Efavirenz and cognition that matters.
    AIDS. 2020;34:1105-1106.
    >> Share

  515. YADAVA SK, Vyas V, Jain H, Fazili T, et al
    Thrombotic thrombocytopenic purpura associated with AIDS: challenges in diagnosis and management.
    AIDS. 2020;34:1101-1102.
    >> Share

  516. ASHIGBIE PG, Laing RO, Wirtz VJ, Nkrumah N, et al
    Registration timelines of antiretroviral medicines in Ghana and Kenya.
    AIDS. 2020;34:1093-1095.
    >> Share

    May 2020
  517. KABAMI J, Balzer LB, Saddiki H, Ayieko J, et al
    Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
    AIDS. 2020 May 28. doi: 10.1097/QAD.0000000000002564.
    >> Share

  518. SOHN AH, Lumbiganon P, Kurniati N, Lapphra K, et al
    Determining standardized causes of death of infants, children, and adolescents living with HIV in Asia.
    AIDS. 2020 May 20. doi: 10.1097/QAD.0000000000002583.
    >> Share

  519. BAJUNIRWE F, Semakula D, Izudi J
    Risk of HIV infection among adolescent girls and young women in age-disparate relationships in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2020 May 20. doi: 10.1097/QAD.0000000000002582.
    >> Share

  520. INZAULE SC, Jordan MR, Bello G, Wadonda-Kabondo N, et al
    High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly-diagnosed antiretroviral treatment naive children in sub-Saharan Africa.
    AIDS. 2020 May 20. doi: 10.1097/QAD.0000000000002580.
    >> Share

  521. CALVERT C, Marston M, Slaymaker E, Crampin AC, et al
    Direct maternal deaths attributable to HIV in the era of ART: evidence from three population-based HIV cohorts with verbal autopsy.
    AIDS. 2020 May 8. doi: 10.1097/QAD.0000000000002552.
    >> Share

  522. GOEDEL WC, Bessey S, Lurie MN, Biello KB, et al
    Projecting the impact of equity-based pre-exposure prophylaxis implementation on racial disparities in HIV incidence among men who have sex with men.
    AIDS. 2020 May 6. doi: 10.1097/QAD.0000000000002577.
    >> Share


  523. Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography-angiography: Erratum.
    AIDS. 2020;34:961.
    >> Share

  524. CICCULLO A, Dusina A, Lassandro AP, Borghetti A, et al
    No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine--dolutegravir.
    AIDS. 2020;34:956-957.
    >> Share

  525. COSTINIUK CT, Jenabian MA
    Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C.
    AIDS. 2020;34:955-956.
    >> Share

  526. SANTOS ME, Protopopescu C, Zucman D, Marcellin F, et al
    Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection.
    AIDS. 2020;34:953-954.
    >> Share

  527. JOHNSTON CD, Ifeagwu KC, Siegler EL, Derry H, et al
    Elevated cardiac risk score by Atherosclerotic Cardiovascular Disease calculation is associated with albuminuria in older people living with HIV.
    AIDS. 2020;34:947-949.
    >> Share

  528. TARAMASSO L, Berruti M, Briano F, Di Biagio A, et al
    The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen.
    AIDS. 2020;34:877-881.
    >> Share

  529. WALMSLEY SL, Ren M, Simon C, Clarke R, et al
    Pilot study assessing the Rotterdam Healthy Aging Score in a cohort of HIV-positive adults in Toronto, Canada.
    AIDS. 2020;34:859-867.
    >> Share

  530. GIANELLA S, Moser C, Vitomirov A, McKhann A, et al
    Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events.
    AIDS. 2020;34:849-857.
    >> Share

  531. LI Y, Altan E, Pilcher C, Hartogensis W, et al
    Semen virome of men with HIV on or off antiretroviral treatment.
    AIDS. 2020;34:827-832.
    >> Share

    April 2020
  532. SU J, Shen X, Ni Q, Zhao H, et al
    Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome.
    AIDS. 2020 Apr 17. doi: 10.1097/QAD.0000000000002553.
    >> Share

  533. LIANG J, Nosova E, Reddon H, Nolan S, et al
    Longitudinal patterns of illicit drug use, ART exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002551.
    >> Share

  534. WHYTE-ALLMAN SK, Hoque MT, Gilmore J, Kaul R, et al
    Drug efflux transporters and metabolic enzymes in human circulating and testicular T-cell subsets: relevance to HIV pharmacotherapy.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002548.
    >> Share

  535. PELUSO MJ, Chen J, Munter S, Reed A, et al
    Outcomes of immunomodulatory and biologic therapy in people living with HIV: a report from two academic hospitals.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002549.
    >> Share

  536. CROWELL CS, Williams PL, Yildirim C, Van Dyke RB, et al
    Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002550.
    >> Share

  537. LACEY A, Savinelli S, Barco EA, Macken A, et al
    Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCDID Cohort.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002541.
    >> Share

  538. VITALLE J, Tarancon-Diez L, Jimenez-Leon MR, Terren I, et al
    CD300a identifies a CD4+ memory T cell subset with a higher susceptibility to HIV-1 infection.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002544.
    >> Share

  539. RAWLINGS SA, Layman L, Smith D, Scott B, et al
    Performing rapid autopsy for the interrogation of HIV reservoirs.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002546.
    >> Share

  540. DI CIACCIO M, Fressard L, Sagaon-Teyssier L, Protiere C, et al
    What are the situational and behavioral factors associated with condomless anal sex without PrEP in men who have sex with men? Results from the ANRS-IPERGAY trial.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002542.
    >> Share

  541. RAMADOSS NS, Zhao NQ, Richardson BA, Grant PM, et al
    Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002543.
    >> Share

  542. KUNISAKI KM, Nouraie M, Jensen R, Chang D, et al
    Lung function in men with and without HIV: a nested cohort substudy.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002526.
    >> Share

  543. PIGGOTT DA, Bandeen-Roche K, Mehta SH, Brown TT, et al
    Frailty transitions, inflammation and mortality among persons aging with HIV infection and injection drug use.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002527.
    >> Share

  544. MAHALE P, Ugoji C, Engels EA, Shiels MS, et al
    Cancer risk following lymphoid malignancies among HIV-infected people.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002528.
    >> Share

  545. NGUYEN N, Choi CJ, Robbins R, Korich R, et al
    Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002529.
    >> Share

  546. PROTIERE C, Fiorentino M, Sow A, Preau M, et al
    Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002530.
    >> Share

  547. WERTHEIM JO, Panneer N, France AM, Saduvala N, et al
    Incident infection in high-priority HIV molecular transmission clusters in the united states.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002531.
    >> Share

  548. AJIBOLA G, Moyo S, Mohammed T, Moseki S, et al
    HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of life.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002532.
    >> Share

  549. NASREDDINE R, Florence E, Vandercam B, Moutschen M, et al
    Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a belgian cohort of 4101 HIV patients.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002533.
    >> Share

  550. DAY S, Mathews A, Blumberg M, Vu T, et al
    Expanding community engagement in HIV clinical trials: a pilot study using crowdsourcing.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002534.
    >> Share

  551. SHARMA V, Bryant C, Montero M, Creegan M, et al
    Monocyte and CD4+ T cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002537.
    >> Share

  552. NJUGUNA I, Neary J, Mburu C, Black D, et al
    Clinic- and individual-level factors that influence HIV viral suppression in adolescents and young adults: a national survey in Kenya.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002538.
    >> Share

  553. TEQUE F, Ye L, Xie F, Wang J, et al
    Genetically-edited iPSCs derived from HIV-1 infected patients on therapy can give rise to immune cells resistant to HIV-1 infection.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002539.
    >> Share

  554. YE L, Wang J, Teque F, Xie F, et al
    Generation of HIV-1 infected patient's gene-edited iPSC using feeder free culture conditions.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002535.
    >> Share

  555. KRUIZE Z, Maurer I, Boeser-Nunnink BDM, Booiman T, et al
    Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002540.
    >> Share

  556. FRIJTERS EM, Hermans LE, Wensing AMJ, Deville WLJM, et al
    Risk factors for loss to follow-up from antiretroviral therapy programmes in low- and middle-income countries: a systematic review and meta-analysis.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002523.
    >> Share

  557. MCMANUS M, Karalius B, Patel K, Persaud D, et al
    Quantitative HIV-1 specific antibodies as predictors of peripheral blood cell-associated HIV-1 DNA concentrations.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002525.
    >> Share

  558. STREHLAU R, Paximadis M, Sherman GG, Abrams EJ, et al
    Response to Zhao and Zhou: Diagnosis of HIV infection in breastfed infants of mothers on antiretroviral therapy.
    AIDS. 2020;34:798-799.
    >> Share

  559. ZHAO H, Zhou YH
    Diagnosis of HIV infection in breastfed infants of mothers on antiretroviral therapy.
    AIDS. 2020;34:797.
    >> Share

  560. HOSODA T, Uehara Y, Kasuga T, Naito T, et al
    An HIV-infected patient with acute retinal necrosis as immune reconstitution inflammatory syndrome due to varicella-zoster virus.
    AIDS. 2020;34:795-796.
    >> Share

  561. WANG X, Boffito M, Dickinson L, Bagkeris E, et al
    Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIV.
    AIDS. 2020;34:790-793.
    >> Share

  562. DELCHER C, Bae J, Rich SN, Klann EM, et al
    Impact of the 12 January 2010 earthquake on HIV case reporting in Haiti.
    AIDS. 2020;34:777-782.
    >> Share

  563. GRAYBILL LA, Kasaro M, Freeborn K, Walker JS, et al
    Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2020;34:761-776.
    >> Share

  564. COTUGNO N, Morrocchi E, Rinaldi S, Rocca S, et al
    Early antiretroviral therapy-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T-cell and B-cell memory.
    AIDS. 2020;34:669-680.
    >> Share

  565. STEWART J, Bukusi E, Celum C, Delany-Moretlwe S, et al
    Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention.
    AIDS. 2020;34:651-658.
    >> Share

    March 2020
  566. TANG EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, et al
    Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis.
    AIDS. 2020 Mar 19. doi: 10.1097/QAD.0000000000002522.
    >> Share

  567. PANPRADIST N, Beck IA, Ruth PS, Avila-Rios S, et al
    Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    AIDS. 2020 Mar 19. doi: 10.1097/QAD.0000000000002524.
    >> Share

  568. BOZZI G, Squillace N, Peri AM, Muscatello A, et al
    Immunological failure in an HIV elite controller: possible role of indirect markers of inflammation and benefit of antiretroviral therapy.
    AIDS. 2020;34:646-647.
    >> Share

  569. GREEN JA, Lum T
    Reply to the letter to the editor: antibody-mediated control of HIV-1 through an alternative pathway.
    AIDS. 2020;34:645.
    >> Share

  570. ANGELOVICH TA, Trevillyan JM, Hoy JF, Wong ME, et al
    Monocytes from men living with HIV exhibit heightened atherogenic potential despite long-term viral suppression with antiretroviral therapy.
    AIDS. 2020;34:513-518.
    >> Share

  571. BREW BJ, McArthur JC
    'A man is as old as his arteries' (attributed to Thomas Sydenham, the English Hippocrates).
    AIDS. 2020;34:637-639.
    >> Share

  572. ALAEI K, Zaidi H
    A centralized or decentralized approach when it comes to socially stigmatized health concerns in conservative social settings.
    AIDS. 2020;34:647-649.
    >> Share

  573. KUMAR RN, Stosor V
    Organ Transplantation in Persons with HIV.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002518.
    >> Share

  574. BEER L, Tie Y, Smith DK, Fagan JL, et al
    Reported Preexposure Prophylaxis (PrEP) Use Among Male Sex Partners of HIV-Positive Men-2016-2018.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002517.
    >> Share

  575. HENTZIEN M, Cuzin L, Raffi F, Jacomet C, et al
    Factors associated with psoriasis in a French Nationwide HIV cohort: the independent role of HLA-B*57: 01.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002519.
    >> Share

  576. LAURENCE J, Elhadad S, Gostynska S, Yu Z, et al
    HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-beta1 and intervention via anti-oxidant pathways.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002516.
    >> Share

  577. CHELICO L, King A, Ticknor J, McDonald M, et al
    Perspectives of Saskatchewan researchers and community members on HIV-1 strains circulating in Saskatchewan.
    AIDS. 2020 Mar 3. doi: 10.1097/QAD.0000000000002515.
    >> Share

  578. SENONER T, Dichtl W, Feuchtner GM
    The perivascular fat gradient in HIV-infected patients.
    AIDS. 2020;34:490-491.
    >> Share

  579. WEST HW, Antoniades C
    The Fat Attenuation Index in HIV-infected patients.
    AIDS. 2020;34:489-490.
    >> Share

  580. WOOD BR
    Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    AIDS. 2020;34:481-482.
    >> Share

  581. STUART RM, Kelly SL, Martin-Hughes R, Wilson DP, et al
    Potential health gains in West and Central Africa through savings from lower cost HIV treatment.
    AIDS. 2020;34:439-446.
    >> Share

  582. ALGHAMDI A, Hempel A, Heendeniya A, Clifford-Rashotte M, et al
    HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures.
    AIDS. 2020;34:433-437.
    >> Share

  583. RIAL-CRESTELO D, Sepulveda MA, Gonzalez-Gasca FJ, Geijo-Martinez P, et al
    Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?
    AIDS. 2020;34:427-432.
    >> Share

  584. JAMES CW, Szabo S, Kahal D, Goldstein ND, et al
    The effect of multivitamins and polyvalent cations on virologic suppression with integrase strand transfer inhibitors.
    AIDS. 2020;34:487-489.
    >> Share

  585. VILLINGER F
    In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene.
    AIDS. 2020;34:487.
    >> Share

    February 2020
  586. XIA Q, Lim S, Wu B, Forgione LA, et al
    Estimating the probability of diagnosis within one year of HIV acquisition.
    AIDS. 2020 Feb 20. doi: 10.1097/QAD.0000000000002510.
    >> Share

  587. DIRAJLAL-FARGO S, Albar Z, Bowman E, Labbato D, et al
    Increased monocyte and T-cell activation in treated HIV+ ugandan children: associations with gut alteration and HIV factors.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002505.
    >> Share

  588. FIELDS JA, Swinton MK, Soontornniyomkij B, Carson A, et al
    Beta amyloid levels in CSF of HIV-infected people vary by exposure to antiretroviral therapy.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002506.
    >> Share

  589. SHIPEOLU L, Sampsel K, Reeves A, Blaskovits F, et al
    HIV nonoccupational postexposure prophylaxis (nPEP) for sexual assault cases: a three-year investigation.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002507.
    >> Share

  590. AVDOSHINA V, Mahoney M, Gilmore SF, Wenzel ED, et al
    HIV influences microtubule associated protein-2: Potential marker of HIV-associated neurocognitive disorders.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002509.
    >> Share

  591. LI GH, Maric D, Major EO, Nath A, et al
    Productive HIV infection in astrocytes can be established via a non-classical mechanism.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002512.
    >> Share

  592. CHASIMPHA SJD, Mclean EM, Dube A, Mccormack V, et al
    Assessing the validity of and factors that influence accurate self-reporting of HIV status after testing: a population-based study.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002513.
    >> Share

  593. SALLEH NAM, Van Draanen J, Nosova E, Barrios R, et al
    Material security and adherence to antiretroviral therapy (ART) among HIV-positive people who use illicit drugs.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002501.
    >> Share

  594. HABER NA, Lesko CR, Fox MP, Powers KA, et al
    Limitations of the UNAIDS 90-90-90 metrics: a simulation-based comparison of cross-sectional and longitudinal metrics for the HIV care continuum.
    AIDS. 2020 Feb 10. doi: 10.1097/QAD.0000000000002502.
    >> Share

  595. ZAUNDERS J, Munier CML, McGuire H, Law H, et al
    Mapping the extent of heterogeneity of human CCR5+ CD4 T-cells in peripheral blood and lymph nodes.
    AIDS. 2020 Feb 10. doi: 10.1097/QAD.0000000000002503.
    >> Share

  596. EDWARDS JK, Arimi P, Ssengooba F, Herce M, et al
    Improving HIV outreach testing yield at cross-border venues in East Africa.
    AIDS. 2020 Feb 10. doi: 10.1097/QAD.0000000000002500.
    >> Share

  597. NISHIJIMA T, Inaba Y, Kawasaki Y, Tsukada K, et al
    Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan.
    AIDS. 2020 Feb 6. doi: 10.1097/QAD.0000000000002498.
    >> Share

  598. TARAMASSO L, Berruti M, Briano F, di Biagio A, et al
    The switch from TDF to TAF determines weight gain in patients on rilpivirine-based regimen.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002496.
    >> Share

  599. LI Y, Altan E, Pilcher C, Hartogensis W, et al
    Semen virome of men with HIV on or off anti-retroviral treatment.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002497.
    >> Share

  600. COHEN J, Pepperrell T, Francois Venter WD
    The same lesson over and over: drugs alone will not get us to 90-90-90.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002494.
    >> Share

  601. MCCAUSLAND MR, Lebron AC, Pilch-Cooper HA, Howell S, et al
    Toll-like receptor distribution in colonic epithelium and lamina propria is disrupted in HIV viremic, immune success and failure.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002499.
    >> Share

  602. VENDRAME E, Seiler C, Ranganath T, Zhao NQ, et al
    TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002488.
    >> Share

  603. STADER F, Decosterd L, Stoeckle M, Cavassini M, et al
    Aging does not impact drug-drug interaction magnitudes with antiretrovirals: a Swiss HIV Cohort Study.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002489.
    >> Share

  604. YANG CT, Toh HS, Liao CT, Kuo S, et al
    Early scale-up of antiretroviral therapy at diagnosis for reducing economic burden of cardiometabolic disease in HIV-infected population.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002490.
    >> Share

  605. SIANGPHOE U, Archer KJ, Nguyen C, Lee KR, et al
    Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1 infected patients.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002491.
    >> Share

  606. JOHNSTON CD, Ifeagwu KC, Siegler EL, Derry H, et al
    Elevated cardiac risk score by ASCVD calculation is associated with albuminuria in older people living with HIV.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002492.
    >> Share

  607. GRAYBILL LA, Kasaro M, Freeborn K, Walker JS, et al
    Incident HIV among pregnant and breastfeeding women in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2020 Feb 3. doi: 10.1097/QAD.0000000000002487.
    >> Share

  608. COTUGNO N, Morrocchi E, Rinaldi S, Rocca S, et al
    Early ART-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T and B cell memory.
    AIDS. 2020 Feb 3. doi: 10.1097/QAD.0000000000002485.
    >> Share

  609. WALMSLEY SL, Ren M, Simon C, Clarke R, et al
    Pilot study assessing the rotterdam healthy aging score in a cohort of human immunodeficiency virus positive adults in Toronto, Canada.
    AIDS. 2020 Feb 3. doi: 10.1097/QAD.0000000000002493.
    >> Share


  610. Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV: Erratum.
    AIDS. 2020;34:333.
    >> Share

  611. ETCHEVERRY-RUFINO F, Lucero C, Lopez-Ceron M, Alenar-Gelabert Y, et al
    Local barrier dysfunction identified by confocal laser endomicroscopy predicts bacterial translocation in HIV infection.
    AIDS. 2020;34:328-331.
    >> Share

  612. CACHAY E
    Do we need to address stigma and mistrust to facilitate hepatitis C elimination among people living with HIV?
    AIDS. 2020;34:325-331.
    >> Share

  613. PEPPERRELL T, Venter WDF, Moorhouse M, McCann K, et al
    Time to rethink endpoints for new clinical trials of antiretrovirals? Long-term re-suppression of HIV RNA with integrase inhibitors.
    AIDS. 2020;34:321-324.
    >> Share

  614. GUARALDI G, Milic J
    Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge?
    AIDS. 2020;34:317-319.
    >> Share


  615. All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.
    AIDS. 2020;34:277-289.
    >> Share

  616. LIN KS, Win S, Nyein PP
    Drug-induced immune hemolytic anemia because of efavirenz: a case report.
    AIDS. 2020;34:326-328.
    >> Share

    January 2020
  617. JAMIESON L, Gomez GB, Rebe K, Brown B, et al
    The impact of self-selection based on HIV risk on the cost-effectiveness of pre-exposure prophylaxis in South Africa.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002486.
    >> Share

  618. GIANELLA S, Moser C, Vitomirov A, McKhann A, et al
    Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002484.
    >> Share

  619. WANG X, Boffito M, Dickinson L, Bagkeris E, et al
    Plasma NRTI concentration and their associations with liver and renal parameters in people living with HIV.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002479.
    >> Share

  620. PHILLIPS TK, Orrell C, Brittain K, Zerbe A, et al
    Measuring retention in HIV care: the impact of data sources and definitions using routine data in South Africa.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002478.
    >> Share

  621. GIRON LB, Papasavvas E, Azzoni L, Yin X, et al
    Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint.
    AIDS. 2020 Jan 17. doi: 10.1097/QAD.0000000000002476.
    >> Share

  622. TASKER C, Pizutelli V, Lo Y, Ramratnam B, et al
    Depot medroxyprogesterone acetate (Depo-Provera) administration increases cervical CCR5+CD4+ T cells and induces immunosuppressive milieu at the cervicovaginal mucosa: a 3-month longitudinal study.
    AIDS. 2020 Jan 16. doi: 10.1097/QAD.0000000000002475.
    >> Share

  623. HORSBURGH BA, Lee E, Hiener B, Eden JS, et al
    High levels of genetically-intact HIV in HLA-DR+ memory T-cells indicates their value for reservoir studies.
    AIDS. 2020 Jan 6. doi: 10.1097/QAD.0000000000002465.
    >> Share

  624. SHROUFI A, Van Cutsem G, Cambiano V, Bansi-Matharu L, et al
    HIV viral load algorithm: what are the needs in the field?: authors' response.
    AIDS. 2020;34:160-162.
    >> Share

  625. MASSAD LS, Xie X, Minkoff H, Kassaye S, et al
    Longitudinal assessment of abnormal Papanicolaou test rates among women with HIV.
    AIDS. 2020;34:73-80.
    >> Share

  626. GRAS J, Mahjoub N, Charreau I, Cotte L, et al
    Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.
    AIDS. 2020;34:47-52.
    >> Share

  627. SVIRIDOV D, Mukhamedova N, Makarov AA, Adzhubei A, et al
    Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.
    AIDS. 2020;34:1-13.
    >> Share

    December 2019
  628. KR KWAA A, Garliss CC, Ritter KD, Laird GM, et al
    Elite suppressors have low frequencies of intact HIV-1 proviral DNA.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002474.
    >> Share

  629. SALOU M, Butel C, Comlan AS, Konou AA, et al
    Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002470.
    >> Share

  630. PAUL RH, Cho KS, Belden AC, Mellins CA, et al
    Machine learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002471.
    >> Share

  631. DELCHER C, Bae J, Rich SN, Klann EM, et al
    Impact of the January 12, 2010 earthquake on HIV case reporting in Haiti: an interrupted time series analysis.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002466.
    >> Share

  632. ALBERT AYK, Elwood C, Wagner EC, Pakzad Z, et al
    Investigation of Factors Associated with Spontaneous Preterm Birth in Pregnant Women Living with HIV.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002464.
    >> Share

  633. STEWART J, Bukusi E, Celum C, Delany-Moretlwe S, et al
    Sexually transmitted infections among African women: an underrecognized epidemic and an opportunity for combination STI/HIV prevention.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002472.
    >> Share

  634. YE J, Hao M, Xing H, Zhang F, et al
    Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: A multicenter observational study.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002468.
    >> Share

  635. REITSEMA M, Van Hoek AJ, Van Der Loeff MS, Hoornenborg E, et al
    Pre-exposure prophylaxis for msm in the netherlands: impact on hiv and n.gonorrhoeae transmission and cost-effectiveness.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002469.
    >> Share

  636. CARR M, Richardson R, Tong W, Bloch M, et al
    Switch from tenofovir DF to raltegravir is not associated with weight gain over 96 weeks.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002473.
    >> Share

  637. MAHEU-GIROUX M, Jahn A, Kalua T, Mganga A, et al
    HIV surveillance based on routine testing data from antenatal clinics in Malawi (2011-2018): measuring and adjusting for bias from imperfect testing coverage.
    AIDS. 2019;33 Suppl 3:S295-S302.
    >> Share

  638. STOVER J, Glaubius R, Mofenson L, Dugdale CM, et al
    Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels.
    AIDS. 2019;33 Suppl 3:S227-S234.
    >> Share

  639. TRICKEY A, van Sighem A, Stover J, Abgrall S, et al
    Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings.
    AIDS. 2019;33 Suppl 3:S271-S281.
    >> Share

  640. EATON JW, Brown T, Puckett R, Glaubius R, et al
    The Estimation and Projection Package Age-Sex Model and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa.
    AIDS. 2019;33 Suppl 3:S235-S244.
    >> Share

  641. BESSON C, Noel N, Lancar R, Prevot S, et al
    HCV or HBV coinfection and lymphoma risk in people living with HIV.
    AIDS. 2019 Dec 10. doi: 10.1097/QAD.0000000000002461.
    >> Share

  642. ORKIN C, Eron JJ, Rockstroh J, Podzamczer D, et al
    Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.
    AIDS. 2019 Dec 10. doi: 10.1097/QAD.0000000000002463.
    >> Share

  643. WOLDESENBET SA, Kufa T, Barron P, Chirombo BC, et al
    Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa: a national cross-sectional survey.
    AIDS. 2019 Dec 9. doi: 10.1097/QAD.0000000000002457.
    >> Share

  644. ANGELOVICH TA, Trevillyan JM, Hoy JF, Wong ME, et al
    Monocytes from men living with HIV exhibit heightened atherogenic potential despite long term viral suppression with ART.
    AIDS. 2019 Dec 5. doi: 10.1097/QAD.0000000000002460.
    >> Share

  645. BRICENO O, Chavez-Torres M, Peralta-Prado A, Garrido-Rogriguez D, et al
    Associations between recent thymic emigrants and CD4+ T cell recovery after short-term antiretroviral therapy initiation.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002458.
    >> Share

  646. ASCHER SB, Scherzer R, Estrella MM, Shigenaga J, et al
    HIV pre-exposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002456.
    >> Share

  647. XIA Q, Wertheim JO, Braunstein SL, Misra K, et al
    Use of molecular HIV surveillance data and predictive modeling to prioritize persons for transmission-reduction interventions.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002452.
    >> Share

  648. KREBS E, Zang X, Enns B, Min JE, et al
    The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002455.
    >> Share

  649. YOUNG PW, Zielinski-Gutierrez E, Wamicwe J, Mukui I, et al
    Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002453.
    >> Share

  650. KAKKAR F, Lee T, Hawkes MT, Brophy J, et al
    Challenges to achieving and maintaining viral suppression among Canadian children living with perinatal HIV infection in the Early Pediatric Initiation Canada Child Cure Cohort.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002454.
    >> Share

  651. MCCRARY AW, Nyandiko W, Ellis AM, Chakraborty H, et al
    Early cardiac dysfunction in children and young adults with perinatally acquired HIV.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002445.
    >> Share


  652. Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories: Erratum.
    AIDS. 2019;33:2451.
    >> Share

  653. DEL PUENTE F, Pontali E, Torresin A, Cassola G, et al
    Long-term safety and efficacy of dolutegravir and unboosted atazanavir among experienced HIV-infected adults.
    AIDS. 2019;33:2446-2447.
    >> Share

  654. BARAKAT E, Oren NC, Vaysberg A
    Symptomatic cerebrospinal fluid HIV escape syndrome in a patient on highly active antiretroviral therapy and suppressed plasma viral load.
    AIDS. 2019;33:2444-2446.
    >> Share

  655. FEITERNA-SPERLING C, Kruger R, Amara A, Khoo S, et al
    Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman.
    AIDS. 2019;33:2443-2444.
    >> Share

  656. MAZZITELLI M, Milinkovic A, Pereira B, Palmer J, et al
    Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV.
    AIDS. 2019;33:2439-2441.
    >> Share

  657. MCHEMBERE W, Agaya J, Yuen CM, Okelloh D, et al
    High yield of new HIV diagnoses during active case-finding for tuberculosis.
    AIDS. 2019;33:2431-2435.
    >> Share

  658. OTIENO G, Whiteside YO, Achia T, Kwaro D, et al
    Decreased HIV-associated mortality rates during scale-up of antiretroviral therapy, 2011-2016.
    AIDS. 2019;33:2423-2430.
    >> Share

  659. MUPFUMI L, Moyo S, Shin SS, Wang Q, et al
    High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
    AIDS. 2019;33:2415-2422.
    >> Share

  660. VENKATESH KK, Farhad M, Fenton T, Moodley D, et al
    Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    AIDS. 2019;33:2403-2413.
    >> Share

  661. THIN K, Frederix K, McCracken S, Letsie M, et al
    Progress toward HIV epidemic control in Lesotho.
    AIDS. 2019;33:2393-2401.
    >> Share

  662. MILINKOVIC A, Berger F, Arenas-Pinto A, Mauss S, et al
    Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back.
    AIDS. 2019;33:2387-2391.
    >> Share

  663. CARLUCCI JG, Liu Y, Clouse K, Vermund SH, et al
    Attrition of HIV-positive children from HIV services in low and middle-income countries.
    AIDS. 2019;33:2375-2386.
    >> Share

  664. KIM-CHANG JJ, Donovan K, Loop MS, Hong S, et al
    Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV.
    AIDS. 2019;33:2363-2374.
    >> Share

  665. YUAN N, Scherzer R, Tanriverdi K, Martin J, et al
    MicroRNA biomarkers associated with type 1 myocardial infarction in HIV-positive individuals.
    AIDS. 2019;33:2351-2361.
    >> Share

  666. LAMPE FC, Rodger AJ, Burman W, Grulich A, et al
    Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison.
    AIDS. 2019;33:2337-2350.
    >> Share

  667. PALELLA FJ, Hart R, Armon C, Tedaldi E, et al
    Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.
    AIDS. 2019;33:2327-2335.
    >> Share

  668. DONALDSON MA, Campbell AR, Albert AY, Borhani M, et al
    Comorbidity and polypharmacy among women living with HIV in British Columbia.
    AIDS. 2019;33:2317-2326.
    >> Share

  669. ANDERSON AM, Perez-Santiago J, Zheng Z, Huang E, et al
    Better executive function is independently associated with full HIV suppression during combination therapy.
    AIDS. 2019;33:2309-2316.
    >> Share

  670. COUNCIL OD, Ruone S, Mock PA, Khalil G, et al
    HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis.
    AIDS. 2019;33:2299-2307.
    >> Share

  671. SAINZ T, Serrano-Villar S, Mann S, Ma ZM, et al
    Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy.
    AIDS. 2019;33:2289-2298.
    >> Share

  672. COSTINIUK CT, Jenabian MA
    Cannabinoids and inflammation: implications for people living with HIV.
    AIDS. 2019;33:2273-2288.
    >> Share

  673. JOSEPH SB, Trunfio M, Kincer LP, Calcagno A, et al
    What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
    AIDS. 2019;33 Suppl 2:S171-S179.
    >> Share

  674. BREW BJ, Barnes SL
    The impact of HIV central nervous system persistence on pathogenesis.
    AIDS. 2019;33 Suppl 2:S113-S121.
    >> Share

  675. WINSTON A, Antinori A, Cinque P, Fox HS, et al
    Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
    AIDS. 2019;33 Suppl 2:S107-S111.
    >> Share

  676. HSU DC, Silsorn D, Inthawong D, Kuncharin Y, et al
    Impact of analytical treatment interruption on the central nervous system in a simian-HIV model.
    AIDS. 2019;33 Suppl 2:S189-S196.
    >> Share

  677. ABREU C, Shirk EN, Queen SE, Beck SE, et al
    Brain macrophages harbor latent, infectious simian immunodeficiency virus.
    AIDS. 2019;33 Suppl 2:S181-S188.
    >> Share

  678. MASTRANGELO A, Turrini F, de Zan V, Caccia R, et al
    Symptomatic cerebrospinal fluid escape.
    AIDS. 2019;33 Suppl 2:S159-S169.
    >> Share

  679. HENDERSON LJ, Johnson TP, Smith BR, Reoma LB, et al
    Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy.
    AIDS. 2019;33 Suppl 2:S145-S157.
    >> Share

  680. SPUDICH S, Peterson J, Fuchs D, Price RW, et al
    Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.
    AIDS. 2019;33 Suppl 2:S135-S144.
    >> Share

  681. SPUDICH S, Clements JE
    HIV persistence in the central nervous system during antiretroviral therapy: evidence and implications.
    AIDS. 2019;33 Suppl 2:S103-S106.
    >> Share

    November 2019
  682. POIZOT-MARTIN I, Lions C, Cheret A, Rey D, et al
    Kaposi sarcoma in people living with HIV: incidence and associated factors in the French DAT'AIDS cohort between 2010 and 2015.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002450.
    >> Share

  683. VEIL R, Poizot-Martin I, Reynes J, Goujard C, et al
    Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002447.
    >> Share

  684. REDDY K, Kelly C, Brown ER, Jeenarain N, et al
    Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002451.
    >> Share

  685. TRICKEY A, van Sighem A, Stover J, Abgrall S, et al
    Parameter estimates for trends and patterns of excess mortality among persons on ART in high-income european settings.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002387.
    >> Share

  686. MAHEU-GIROUX M, Marsh K, Doyle C, Godin A, et al
    National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the "first 90" from program and survey data.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002386.
    >> Share

  687. MEYERS T, Samson P, Acosta EP, Moye J, et al
    Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
    AIDS. 2019;33:2197-2203.
    >> Share

  688. THORNHILL JP, Lynch KD, Skelton JK, Dorner M, et al
    Vedolizumab use and the associations between alpha4beta7 expression and HIV reservoir in the gut during treated primary HIV infection.
    AIDS. 2019;33:2268-2271.
    >> Share

  689. DUARTE F, Soares MA
    Simplified two-drug antiretroviral HIV treatment: novel data and expected impact.
    AIDS. 2019;33:2266-2268.
    >> Share

  690. TSUKAMOTO T
    Spontaneous HIV controllers might be the key to prevent accelerated immunosenescence of effector CD8+ T cells.
    AIDS. 2019;33:2253-2255.
    >> Share

  691. WILLIAMS DW, Elahi S
    Profound immune consequences for young adults infected with HIV perinatally or during childhood: a cautionary tale regarding adherence to antiretroviral therapy.
    AIDS. 2019;33:2251-2252.
    >> Share

  692. UMLAUF A, Soontornniyomkij B, Sundermann EE, Gouaux B, et al
    Risk of developing cerebral beta-amyloid plaques with posttranslational modification among HIV-infected adults.
    AIDS. 2019;33:2157-2166.
    >> Share

  693. HENRIQUEZ S, Lecuroux C, Bitu M, Avettand-Fenoel V, et al
    The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.
    AIDS. 2019;33:2137-2147.
    >> Share

  694. RIAL-CRESTELO D, Sepulveda MA, Gonzalez-Gasca FJ, Geijo-Martinez P, et al
    Does fibrosis really regress in HIV/HCV co-infected patients after treatment with direct-antiviral agents?
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002433.
    >> Share

  695. MORANGUINHO I, Borrego P, Goncalves F, Gomes P, et al
    Genotypic resistance profiles of HIV-2 infected patients from Cape Verde failing first-line antiretroviral therapy.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002431.
    >> Share

  696. HOFFMAN RM, Balakasi K, Bardon AR, Siwale Z, et al
    Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002435.
    >> Share

  697. ALGHAMDI A, Hempel A, Heendeniya A, Clifford-Rashotte M, et al
    HIV post-exposure prophylaxis-in-pocket ("PIP"): long-term follow-up of individuals with low-frequency, high-risk HIV exposures.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002441.
    >> Share

  698. JAMES KS, Trumble I, Clohosey ML, Moeser M, et al
    Measuring the contribution of gammadelta T cells to the persistent HIV reservoir.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002434.
    >> Share

  699. LIPSHULTZ SE, Sasaki N, Thompson B, Eidem BW, et al
    Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002443.
    >> Share

  700. ELLER MA, Hong T, Creegan M, Nau ME, et al
    Activated PD-1+ CD4 T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002432.
    >> Share

  701. LUPIA T, Milia MG, Atzori C, Gianella S, et al
    Presence of EBV DNA in Cerebrospinal Fluid is Associated with Greater HIV RNA and Inflammation.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002442.
    >> Share

  702. EATON JW, Brown T, Puckett R, Glaubius R, et al
    EPP-ASM and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002437.
    >> Share

  703. CASE KK, Johnson LF, Mahy M, Marsh K, et al
    Summarizing the results and methods of the 2019 UNAIDS HIV estimates.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002440.
    >> Share

  704. KALLIANPUR KJ, Jahanshad N, Sailasuta N, Benjapornpong K, et al
    Regional brain volumetric changes despite two years of treatment initiated during acute HIV infection.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002436.
    >> Share

  705. PURYEAR SB, Balzer LB, Ayieko J, Kwarisiima D, et al
    Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002427.
    >> Share

  706. LE BERRE AP, Fama R, Sassoon SA, Zahr NM, et al
    Cognitive impairment severity in relation to signs of subclinical Wernicke's encephalopathy in HIV and alcoholism comorbidity.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002428.
    >> Share

  707. MENEZES EGM, Ramallho J, Bucovsky M, Shane E, et al
    Serum extracellular vesicles expressing bone activity markers associate with bone loss after HIV antiretroviral therapy.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002430.
    >> Share

  708. PEPPERRELL T, Venter WDF, Moorhouse M, McCann K, et al
    Time to rethink endpoints for new antiretroviral regimen registration? HIV RNA re-suppression in the ADVANCE trial.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002422.
    >> Share

  709. GRAY DM, Wedderburn CJ, MacGinty RP, McMillan L, et al
    Impact of HIV and antiretroviral drug exposure on lung growth and function over 2 years in an African Birth Cohort.
    AIDS. 2019 Nov 11. doi: 10.1097/QAD.0000000000002444.
    >> Share

  710. SAFARPOUR H, Cevik M, Zarean M, Barac A, et al
    Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV: A systematic review and meta-analysis.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002424.
    >> Share

  711. VIZCARRA P, Vivancos MJ, Perez-Elias MJ, Moreno A, et al
    Weight gain in people living with HIV switched to dual therapy: changes in body fat mass.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002421.
    >> Share

  712. VAN BILSEN WPH, Boyd A, van der Loeff MFS, Davidovich U, et al
    Diverging trends in incidence of HIV versus other sexually transmitted infections in HIV-negative men who have sex with men (MSM) in Amsterdam.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002417.
    >> Share

  713. TENORE SB, Avelino-Silva VI, Costa PR, Franco LM, et al
    Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T cell recovery: a randomized trial.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002420.
    >> Share

  714. MAFFEI VJ, Ferguson TF, Brashear MM, Mercante DE, et al
    Lifetime alcohol use among persons living with hiv is associated with frailty.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002426.
    >> Share

  715. NDUAGUBA SO, Barner JC, Ford KH, Lawson KA, et al
    Association between quality of care indicators for HIV infection and healthcare resource utilization and costs.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002418.
    >> Share

  716. STUART RM, Kelly SL, Martin-Hughes R, Wilson DP, et al
    Potential health gains among key populations in West and Central Africa through savings from lower-cost HIV treatment.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002419.
    >> Share

  717. BRETON G, Laborde-Balen G, Guilavogui F, Karemangino S, et al
    HIV viral load algorithm, what are the needs in the field?
    AIDS. 2019 Nov 5. doi: 10.1097/QAD.0000000000002382.
    >> Share

  718. UNDERWOOD ML, Nguyen T, Uebelhoer LS, Kunkel LE, et al
    Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder.
    AIDS. 2019 Nov 4. doi: 10.1097/QAD.0000000000002416.
    >> Share

  719. BOCCHER-LATTIMORE D, Millery M, McKinnon K, Li M, et al
    Workforce development needs in HIV care: a response to mental health and HIV/AIDS: the need for an integrated response.
    AIDS. 2019;33:2109-2110.
    >> Share

  720. OLAKUNDE BO, Pharr JR, Adeyinka DA, Danquah P, et al
    HIV-related risk behaviors and testing among adolescent gay and bisexual boys in the United States.
    AIDS. 2019;33:2107-2109.
    >> Share

  721. MARTINEZ-REBOLLAR M, Pascual PP, de la Mora L, Londono MC, et al
    Contributing awareness of autoimmune hepatitis in HIV patients.
    AIDS. 2019;33:2103-2105.
    >> Share

  722. TEASDALE CA, Yuengling KA, Mutiti A, Arpadi S, et al
    Delays in fast track antiretroviral therapy initiation and reasons for not starting treatment among eligible children in Eastern Cape, South Africa.
    AIDS. 2019;33:2099-2101.
    >> Share

  723. MEYERS DJ, Cole MB, Rahman M, Lee Y, et al
    The association of provider and practice factors with HIV antiretroviral therapy adherence.
    AIDS. 2019;33:2081-2089.
    >> Share

  724. BRENNAN AT, Berry KM, Rosen S, Stokes A, et al
    Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.
    AIDS. 2019;33:2049-2059.
    >> Share

    October 2019
  725. SEBASTIANI G, Saeed S, Lebouche B, de Pokomandy A, et al
    Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients.
    AIDS. 2019 Oct 16. doi: 10.1097/QAD.0000000000002412.
    >> Share

  726. SUTCLIFFE CG, Drogt CS, van Dijk JH, Hamangaba F, et al
    Timing of and factors associated with HIV disclosure among perinatally infected children in rural Zambia.
    AIDS. 2019 Oct 16. doi: 10.1097/QAD.0000000000002411.
    >> Share

  727. FOSTER C, Ayers S, Mcdonald S, Frize G, et al
    Clinical outcomes post transition to adult services in young adults with perinatally acquired HIV infection: mortality, retention in care, and viral suppression.
    AIDS. 2019 Oct 16. doi: 10.1097/QAD.0000000000002410.
    >> Share

  728. AIZIRE J, Sikorskii A, Ogwang LW, Kawalazira R, et al
    Decreased growth among antiretroviral drug and HIV exposed uninfected versus unexposed children in Malawi and Uganda.
    AIDS. 2019 Oct 12. pii: 00002030-900000000-00001.
    >> Share

  729. CHAISSON LH, Saraceni V, Cohn S, Seabrook D, et al
    CD4 count stratification to guide tuberculosis preventive therapy for people living with HIV.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002398.
    >> Share

  730. GANDHI M, Wang G, King R, Rodrigues WC, et al
    Development and Validation of the First Point-of-Care Assay to Objectively Monitor Adherence to HIV Treatment and Prevention in Real-Time in Routine Settings.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002395.
    >> Share

  731. DEL AMO J, Jarrin I
    All-cause mortality after ART initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002399.
    >> Share

  732. LESOSKY M, Raboud JM, Glass T, Brummel SS, et al
    Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa: a simulation study.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002400.
    >> Share

  733. LI Y, Liu H, Ramadhani HO, Ndembi N, et al
    Genetic Clustering Analysis for HIV Infection among Men Who Have Sex with Men in Nigeria: implications for intervention.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002409.
    >> Share

  734. MACATANGAY BJC, Gandhi RT, Brad Jones R, Mcmahon DK, et al
    PD-1HI T cells are associated with lower hiv-specific immune responses despite long-term antiretroviral therapy.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002406.
    >> Share

  735. CHANG K, Premeaux TA, Cobigo Y, Milanini B, et al
    Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002404.
    >> Share

  736. ZHANG HQ, Xia P, Huang HH, Zhang C, et al
    CD4+CD19+ conjugates favor HIV-1 infection and latency during chronic HIV-1 infection.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002402.
    >> Share

  737. COUNCIL OD, Ruone S, Mock PA, Khalil G, et al
    HIV-1 genetic diversity to estimate time of infection and infer adherence to pre-exposure prophylaxis.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002390.
    >> Share

  738. HSU DC, Ma YF, Narwan A, Rahalkar S, et al
    Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infection.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002389.
    >> Share

  739. FOGEL JM, Sivay MV, Cummings V, Wilson EA, et al
    HIV drug resistance in a cohort of HIV-infected men who have sex with men in the United States.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002394.
    >> Share

  740. MORAN CA, Southmayd G, Devireddy CM, Quyyumi AA, et al
    Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002393.
    >> Share

  741. OGBUOJI O, Geldsetzer P, Wong C, Khan S, et al
    Impact of immediate initiation of antiretroviral therapy on HIV patient satisfaction: a stepped-wedge cluster-randomized controlled trial.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002392.
    >> Share

  742. MEZA G, Exposito A, Royo JL, Ruiz-Garcia C, et al
    Association of CR2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 Vaccine.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002401.
    >> Share

  743. MAZZITELLI M, Milinkovic A, Pereira B, Palmer J, et al
    Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002403.
    >> Share

  744. BARRY PA, Deere JD, Yue Y, Chang WW, et al
    Cytomegalovirus (CMV)-Vectored vaccines for HIV and other pathogens.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002396.
    >> Share

  745. ABBAR B, Baron M, Katlama C, Marcelin AG, et al
    Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002397.
    >> Share

  746. LIU L, Dai L, Yao J, Pan P, et al
    Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naive individuals in a tertiary care hospital in Beijing, China.
    AIDS. 2019;33:1945-1947.
    >> Share


  747. Strong sex bias in elite control of paediatric HIV infection: Erratum.
    AIDS. 2019;33:1959.
    >> Share


  748. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix): Erratum Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection: E
    AIDS. 2019;33:1957.
    >> Share

  749. GUILLE M, Rousset S, Bonneville F, Mengelle C, et al
    IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapy.
    AIDS. 2019;33:1954-1956.
    >> Share

  750. HAMMERSCHLAG Y, Korman TM, Woolley IJ
    HIV presenting as AIDS in previously undiagnosed tourists in a low-prevalence setting.
    AIDS. 2019;33:1952-1954.
    >> Share

  751. FAUSTINO E, Fielding J, Teutsch S
    Eliminating the HIV epidemic: the US government can make preexposure prophylaxis affordable now.
    AIDS. 2019;33:1951-1952.
    >> Share

  752. STOPARD IJ, Hauck K, Hallett TB
    The influence of constraints on the efficient allocation of resources for HIV prevention: authors' response.
    AIDS. 2019;33:1950-1951.
    >> Share

  753. STUART RM, Kelly SL, Kerr CC, Martin-Hughes R, et al
    The influence of constraints on the efficient allocation of resources for HIV prevention.
    AIDS. 2019;33:1949-1950.
    >> Share

  754. BREW BJ, McArthur J
    Distinguishing cognitive impairment from HIV-associated neurocognitive disorder versus substance use?
    AIDS. 2019;33:1943-1944.
    >> Share

  755. KHANNA AS, Schneider JA, Collier N, Ozik J, et al
    A modeling framework to inform preexposure prophylaxis initiation and retention scale-up in the context of 'Getting to Zero' initiatives.
    AIDS. 2019;33:1911-1922.
    >> Share

  756. CASTRO FOF, Silva JM, Dorneles GP, Barros JBS, et al
    Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine.
    AIDS. 2019;33:1831-1842.
    >> Share

  757. SVIRIDOV D, Mukhamedova N, Makarov AA, Adzhubei A, et al
    Co-morbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.
    AIDS. 2019 Oct 1. doi: 10.1097/QAD.0000000000002385.
    >> Share

    September 2019
  758. CHAKRABORTY A, Qato DM, Awadalla S, Hershow RC, et al
    Antiretroviral therapy adherence among treatment-naive HIV-infected patients: A retrospective cohort study.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002384.
    >> Share

  759. VAN DE WIJGERT JHHM, Gill AC, Chikandiwa A, Verwijs MC, et al
    Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002381.
    >> Share

  760. KENDALL EA, Durovni B, Martinson NA, Cavalacante S, et al
    Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002380.
    >> Share

  761. BURNS JE, Stirrup OT, Dunn D, Runcie-Unger I, et al
    No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002379.
    >> Share

  762. GENEROSO M, Alvarez P, Kravietz A, Mwamzuka M, et al
    High soluble CD163 levels correlate with disease progression and inflammation in kenyan children with perinatal hiv-infection.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002378.
    >> Share

  763. MCHALE JV, Aviles MAR
    Brexit and UK citizens with HIV residing in Spain: A matter of public health.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002376.
    >> Share

  764. LAPADULA G, Bernasconi DP, Bai F, Foca E, et al
    Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances: Results from a randomized controlled trial.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002377.
    >> Share

  765. MARSH K, Eaton JW, Mahy M, Sabin K, et al
    Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002355.
    >> Share

  766. COURLET P, Stader F, Guidi M, Saldanha SA, et al
    Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging patients enrolled in the Swiss HIV Cohort Study.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002372.
    >> Share

  767. VENKATESH KK, Farhad M, Fenton T, Moodley D, et al
    Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002367.
    >> Share

  768. MUPFUMI L, Moyo S, Shin SS, Wang Q, et al
    High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002363.
    >> Share

  769. YUAN N, Scherzer R, Tanriverdi K, Martin J, et al
    MicroRNA biomarkers associated with type 1 myocardial infarction in HIV positive individuals.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002368.
    >> Share

  770. OTIENO G, Whiteside YO, Achia T, Kwaro D, et al
    Decreased HIV-associated mortality rates during scale-up of antiretroviral therapy, 2011-2016: a population-based cohort study.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002374.
    >> Share

  771. FEITERNA-SPERLING C, Kruger R, Amara A, Khoo S, et al
    Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1 infected women.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002360.
    >> Share

  772. LAMPE FC, Rodger AJ, Burman W, Grulich A, et al
    Impact of early antiretroviral treatment on sexual behaviour in the INSIGHT Strategic Timing of Anti-Retroviral Treatment (START) Trial.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002359.
    >> Share

  773. KIM-CHANG JJ, Donovan K, Loop MS, Hong S, et al
    Higher soluble CD14 levels are associated with lower visuospatial memory performance in Youth with HIV (YWH).
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002371.
    >> Share

  774. CARLUCCI JG, Liu Y, Clouse K, Vermund SH, et al
    Attrition of HIV-positive children from HIV services in low- and middle-income countries: a systematic review and meta-analysis.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002366.
    >> Share

  775. NELSON JAE, de Paris K, Ramirez C, Edmonds A, et al
    Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002373.
    >> Share

  776. MAUGHAN-BROWN B, Venkataramani A, Kharsany AB, Beckett S, et al
    Recently formed age-disparate partnerships are associated with elevated HIV incidence among young women in South Africa.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002362.
    >> Share

  777. GRAS J, Mahjoub N, Charreau I, Cotte L, et al
    Early diagnosis and risk factors of acute hepatitis c in high-risk men who have sex with men on pre-exposure prophylaxis.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002364.
    >> Share

  778. SAINZ T, Serrano-Villar S, Mann S, Ma ZM, et al
    Delayed GALT reconstitution in duodenum compared to rectum in hiv-infected patients initiating antiretroviral therapy.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002361.
    >> Share

  779. JOSKA JA, Dreyer AJ, Nightingale S, Combrinck MI, et al
    Prevalence of HIV-1 Infection in an elderly rural population and associations with neurocognitive impairment.
    AIDS. 2019;33:1765-1771.
    >> Share

  780. KOUAMOU V, Manasa J, Katzenstein D, McGregor AM, et al
    Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy.
    AIDS. 2019;33:1729-1737.
    >> Share

  781. SHAHAR E, Shapiro A, Baskin L, Oz ZK, et al
    Antiretroviral therapy-induced negative HIV antibody test following diagnosis of HIV infection.
    AIDS. 2019;33:1804-1805.
    >> Share

  782. SUZUKI T, Uemura H, Yanagawa Y, Mizushima D, et al
    Successful treatment for Kaposi sarcoma inflammatory cytokine syndrome in a severe CD4+ lymphocytopenic HIV patient.
    AIDS. 2019;33:1801-1802.
    >> Share

  783. BREW BJ, Paul R
    HIV-associated neurocognitive disorder, extracellular vesicles and gender: vive la difference?
    AIDS. 2019;33:1795-1796.
    >> Share

    August 2019
  784. MILINKOVIC A, Berger F, Arenas-Pinto A, Mauss S, et al
    Lipid changes due to tenofovir alafenamide are reversible by switching back to tenofovir disoproxil fumarate.
    AIDS. 2019 Aug 29. doi: 10.1097/QAD.0000000000002350.
    >> Share

  785. MCHEMBERE W, Agaya J, Yuen CM, Okelloh D, et al
    High yield of new HIV diagnoses during active case-finding for tuberculosis.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002354.
    >> Share

  786. DONALDSON MA, Campbell AR, Albert AY, Borhani M, et al
    Comorbidity and polypharmacy among women living with HIV in British Columbia.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002353.
    >> Share

  787. KIDMAN R, Kohler HP
    Adverse childhood experiences, sexual debut and HIV testing among adolescents in a low-income high HIV-prevalence context.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002352.
    >> Share

  788. THIN K, Frederix K, McCracken S, Letsie M, et al
    Progress toward HIV epidemic control in lesotho: results from a population-based survey.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002351.
    >> Share

  789. PALELLA FJ JR, Hart R, Armon C, Tedaldi E, et al
    Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002349.
    >> Share

  790. ANDERSON AM, Perez-Santiago J, Zheng Z, Huang E, et al
    Better executive function is independently associated with full HIV suppression during combination therapy.
    AIDS. 2019 Aug 20. doi: 10.1097/QAD.0000000000002348.
    >> Share

  791. SCOTT HM, Spinelli M, Vittinghoff E, Morehead-Gee A, et al
    Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics.
    AIDS. 2019 Aug 20. doi: 10.1097/QAD.0000000000002347.
    >> Share

  792. MONTGOMERY ET, Roberts ST, Nel A, Malherbe M, et al
    Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence.
    AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002346.
    >> Share

  793. COSTINIUK CT, Jenabian MA
    Cannabinoids and inflammation: Implications for People Living with HIV.
    AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345.
    >> Share

  794. KREMER WW, Van Zummeren M, Breytenbach E, Richter KL, et al
    The use of molecular markers for cervical screening of women living with hiv in South Africa.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002325.
    >> Share

  795. MAHIANE SG, Marsh K, Glaubius R, Eaton JW, et al
    Estimating and projecting the number of new HIV diagnoses and incidence in Spectrum's case surveillance and vital registration tool.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002324.
    >> Share

  796. HENRIQUEZ S, Lecuroux C, Bitu M, Avettand-Fenoel V, et al
    The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002342.
    >> Share

  797. ROXBY AC, Yuhas K, Farquhar C, Bosire R, et al
    Mycoplasma genitalium infection among HIV-infected pregnant African women and implications for mother-to-child transmission of HIV.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002335.
    >> Share

  798. RYOM L, Lundgren JD, Law M, Kirk O, et al
    Serious clinical events in HIV-positive persons with chronic kidney disease (CKD).
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002331.
    >> Share

  799. PALANEE-PHILLIPS T, Brown ER, Szydlo D, Matovu Kiweewa F, et al
    Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
    AIDS. 2019;33:1619-1622.
    >> Share

  800. FAURHOLT-JEPSEN D, Olsen MF, Andersen AB, Kaestel P, et al
    Hyperglycemia and insulin function in antiretroviral treatment-naive HIV patients in Ethiopia: a potential new entity of diabetes in HIV?
    AIDS. 2019;33:1595-1602.
    >> Share

  801. GROSSMAN MA, Hofmann C, Ng HL, Yang OO, et al
    Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.
    AIDS. 2019;33:1565-1574.
    >> Share

  802. KEARNS AC, Velasquez S, Liu F, Dai S, et al
    Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.
    AIDS. 2019;33:1557-1564.
    >> Share

  803. CAPPELLETTI A, Peri AM, Bisi L, Sabbatini F, et al
    Recurrent posterior reversible encephalopathy syndrome in an HIV-HCV coinfected liver transplant recipient.
    AIDS. 2019;33:1679-1681.
    >> Share

  804. FLYNN PM, Abrams EJ
    Response to correspondence entitled: Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1675-1677.
    >> Share

  805. DAUBY N
    Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1674-1675.
    >> Share

  806. RIZZARDO S, Lanzafame M, Lattuada E, Luise D, et al
    Dolutegravir monotherapy and body weight gain in antiretroviral naive patients.
    AIDS. 2019;33:1673-1674.
    >> Share

  807. PANTAZIS N, Papastamopoulos V, Paparizos V, Metallidis S, et al
    Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
    AIDS. 2019;33:1645-1655.
    >> Share

  808. SHROUFI A, Van Cutsem G, Cambiano V, Bansi-Matharu L, et al
    Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.
    AIDS. 2019;33:1635-1644.
    >> Share

  809. MORGELLO S, Gensler G, Sherman S, Ellis RJ, et al
    Frailty in medically complex individuals with chronic HIV.
    AIDS. 2019;33:1603-1611.
    >> Share

  810. RIZZARDINI G, Gori A, Miralles C, Olalla J, et al
    Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen.
    AIDS. 2019;33:1583-1593.
    >> Share

  811. UMLAUF A, Soontornniyomkij B, Sundermann EE, Gouaux B, et al
    Risk of developing cerebral beta-amyloid plaques with post-translational modification among HIV-infected adults.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002336.
    >> Share

  812. LE CN, Britto P, Brummel SS, Hoffman RM, et al
    Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared to men.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002334.
    >> Share

  813. REQUENA S, Caballero E, Lozano AB, Rios-Villegas MJ, et al
    Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002338.
    >> Share

  814. KNUDSEN AD, Kofoed KF, Gelpi M, Sigvardsen PE, et al
    Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002327.
    >> Share

  815. MEINCK F, Pantelic M, Spreckelsen TF, Orza L, et al
    Interventions to reduce gender-based violence among young people living with or affected by HIV/AIDS in low- and middle- income countries.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002337.
    >> Share

  816. FRENCH M
    Antibody-mediated control of HIV-1 infection through an alternative pathway.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002313.
    >> Share

    July 2019
  817. MAHY M, Marsh K, Sabin K, Wanyeki I, et al
    HIV estimates through 2018: data for decision making.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002321.
    >> Share

  818. MEYERS DJ, Cole MB, Rahman M, Lee Y, et al
    The association of provider and practice factors with HIV ART adherence.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002316.
    >> Share

  819. WANG Y, Brummel SS, Beilstein-Wedel E, Dagnall CL, et al
    Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002317.
    >> Share

  820. NEESGAARD B, Pelchen-Matthews A, Ryom L, Florence E, et al
    Uptake and effectiveness of two-drug compared to three-drug antiretroviral Regimens among HIV-positive Individuals in Europe.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002320.
    >> Share

  821. CEDARBAUM E, Ma Y, Scherzer R, Price JC, et al
    Contributions of HIV, HCV, and traditional vascular risk factors to peripheral artery disease in women.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002319.
    >> Share

  822. DE LAZZARI E, Lonca M, Rojas J, Gonzalez-Cordon A, et al
    A 24-week pilot study of dual maintenance therapy with raltegravir plus lamivudine.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002311.
    >> Share

  823. TRUONG HM, O'keefe KJ, Pipkin S, Liegler T, et al
    How are transgender women acquiring hiv? insights from phylogenetic transmission clusters in San Francisco.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002318.
    >> Share

  824. WANG Z, Molsberry SA, Cheng Y, Kingsley L, et al
    Cross-sectional analysis of cognitive function in the MACS with multivariate normative comparisons.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002312.
    >> Share

  825. RICHERT-SPUHLER LE, Pattacini L, Plews M, Irungu E, et al
    Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in HSV-2 seropositive women.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002323.
    >> Share


  826. Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission: Erratum.
    AIDS. 2019;33:1543.
    >> Share

  827. TENFORDE MW, Meintjes G, Mokomane M, Harrison TS, et al
    Low-cerebrospinal fluid white cell counts and mortality in HIV-associated pneumococcal meningitis.
    AIDS. 2019;33:1539-1541.
    >> Share

  828. XIA Q, Abraham B, Shah D, Ramaswamy C, et al
    Authors' reply, Xia et al.
    AIDS. 2019;33:1537-1539.
    >> Share

  829. KEMP CG, Lipira L, Huh D, Nevin PE, et al
    HIV stigma and viral load among African-American women receiving treatment for HIV.
    AIDS. 2019;33:1511-1519.
    >> Share

  830. CITERNE Q, Boyer L, Moreau E, Garon J, et al
    Cluster headache-like symptoms during treatment with tenofovir disoproxil fumarate and emtricitabine.
    AIDS. 2019;33:1535-1536.
    >> Share

  831. FLEMING J, Mathews WC, Rutstein RM, Aberg J, et al
    Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002306.
    >> Share

  832. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    >> Share

  833. PATEL RC, Stalter RM, Thomas KK, Tamraz B, et al
    A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002308.
    >> Share

  834. TEASDALE CA, Yuengling KA, Mutiti A, Arpadi S, et al
    Delays in fast track ART initiation and reasons for not starting treatment among eligible children in Eastern Cape, South Africa.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002309.
    >> Share

  835. DURIER C, Desaint C, Lelievre JD, Silbermann B, et al
    Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002310.
    >> Share

  836. THOMPSON-PAUL AM, Palella FJ Jr, Rayeed N, Ritchey MD, et al
    Excess heart age in adult outpatients in routine HIV care.
    AIDS. 2019 Jul 3. doi: 10.1097/QAD.0000000000002304.
    >> Share

  837. KACANEK D, Huo Y, Malee K, Mellins CA, et al
    Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV.
    AIDS. 2019 Jul 3. doi: 10.1097/QAD.0000000000002301.
    >> Share

  838. POUDYAL D, Yang J, Chen Q, Goswami S, et al
    IL-27 posttranslationally regulates Y-box binding protein-1 to inhibit HIV-1 replication in human CD4+ T cells.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002288.
    >> Share

  839. SACKS JA, Fong Y, Gonzalez MP, Andreotti M, et al
    Performance of cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure: a clinical meta-analysis.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002303.
    >> Share

  840. BRENNAN AT, Berry KM, Rosen S, Stokes A, et al
    Growth curve modelling to determine distinct body mass index trajectory groups in HIV-positive adults on ART in South Africa.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002302.
    >> Share

  841. CHAGANTI J, Marripudi K, Staub LP, Rae CD, et al
    Imaging correlates of the Blood Brain Barrier disruption in HIV associated neurocognitive disorder and therapeutic implications.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002300.
    >> Share

  842. CRICHTON S, Belfrage E, Collins IJ, Doerholt K, et al
    Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002294.
    >> Share

  843. KHANNA AS, Schneider JA, Collier N, Ozik J, et al
    A modeling framework to inform PrEP initiation and retention scale-up in the context of Getting to Zero Initiatives.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002290.
    >> Share

  844. VELEZ-DIAZ-PALLARES M
    Are we using the correct methods to measure efficacy in HIV trials?
    AIDS. 2019;33:1408-1409.
    >> Share

  845. TEN BRINK D, Martin-Hughes R, Kelly SL, Wilson DP, et al
    What is the impact of a 20% funding cut in international HIV aid from the United States?
    AIDS. 2019;33:1406-1408.
    >> Share

  846. MBAE M, Owen L, Elisha KK, Ndhere A, et al
    Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya.
    AIDS. 2019;33:1404-1406.
    >> Share

  847. KAY A, Moser C, McKhann A, Vargas M, et al
    Soluble suppression of tumorigenicity 2 levels are not predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression.
    AIDS. 2019;33:1397-1399.
    >> Share

  848. SHARMA S, Schlusser KE, de la Torre P, Tambussi G, et al
    The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
    AIDS. 2019;33:1335-1344.